gamma-Interferon	B-protein
-induced	O
resistance	O
to	O
1	O
,	O
25-	O
(	O
OH	O
)	O
2	O
D3	O
in	O
human	B-cell_type
monocytes	I-cell_type
and	O
macrophages	B-cell_type
:	O
a	O
mechanism	O
for	O
the	O
hypercalcemia	O
of	O
various	O
granulomatoses	O
.	O

The	O
hypercalcemia	O
of	O
various	O
granulomatoses	O
is	O
caused	O
by	O
endogenous	O
1	O
,	O
25-dihydroxyvitamin	O
D	O
[	O
1	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
]	O
overproduction	O
by	O
disease-activated	O
macrophages	B-cell_type
.	O

The	O
inability	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
to	O
suppress	O
its	O
synthesis	O
in	O
macrophages	B-cell_type
contrasts	O
with	O
the	O
tight	O
control	O
of	O
its	O
production	O
in	O
macrophage	O
precursors	O
,	O
peripheral	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
(	O
PBM	B-cell_type
)	O
.	O

We	O
examined	O
whether	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
resistance	O
develops	O
as	O
PBM	B-cell_type
differentiate	O
to	O
macrophages	B-cell_type
or	O
with	O
macrophage	O
activation	O
.	O

Normal	O
human	B-cell_type
pulmonary	I-cell_type
alveolar	I-cell_type
macrophages	I-cell_type
(	O
PAM	B-cell_type
)	O
are	O
less	O
sensitive	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
than	O
PBM	B-cell_type
,	O
despite	O
similar	O
vitamin	B-protein
D	I-protein
receptor	I-protein
content	O
;	O
however	O
,	O
both	O
PBM	B-cell_type
and	O
PAM	B-cell_type
respond	O
to	O
exogenous	O
1	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
by	O
inhibiting	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
synthesis	O
and	O
inducing	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
degradation	O
through	O
enhancement	O
of	O
24-hydroxylase	B-protein
mRNA	O
levels	O
and	O
activity	O
.	O

The	O
human	B-cell_line
monocytic	I-cell_line
cell	I-cell_line
line	I-cell_line
THP-1	B-cell_line
mimics	O
PAM	B-cell_type
in	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
synthesis	O
and	O
sensitivity	O
to	O
exogenous	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
.	O

We	O
utilized	O
THP-1	B-cell_line
cells	I-cell_line
to	O
examine	O
the	O
response	O
to	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
with	O
macrophage	O
activation	O
.	O

Activation	O
of	O
THP-1	B-cell_line
cells	I-cell_line
with	O
gamma-interferon	B-protein
(	O
gamma-IFN	B-protein
)	O
enhances	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
synthesis	O
30-fold	O
,	O
blocks	O
1	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
suppression	O
of	O
its	O
synthesis	O
,	O
and	O
reduces	O
by	O
42.2	O
%	O
1	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
induction	O
of	O
its	O
degradation	O
.	O

The	O
antagonistic	O
effects	O
of	O
gamma-IFN	B-protein
are	O
not	O
merely	O
restricted	O
to	O
enzymatic	O
activities	O
.	O

In	O
THP-1	B-cell_line
cells	I-cell_line
and	O
in	O
normal	O
PBM	B-cell_type
,	O
gamma-IFN	B-protein
inhibits	O
1	O
,	O
25-	O
(	O
OH	O
)	O
2D3	O
induction	O
of	O
24-hydroxylase	B-protein
mRNA	O
levels	O
without	O
reducing	O
mRNA	O
stability	O
,	O
suggesting	O
gamma-IFN	B-protein
inhibition	O
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
transactivating	O
function	O
.	O

These	O
results	O
explain	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
overproduction	O
in	O
granulomatoses	O
and	O
demonstrate	O
potent	O
inhibition	O
by	O
gamma-IFN	B-protein
of	O
1	O
,	O
25	O
(	O
OH	O
)	O
2D3	O
action	O
in	O
immune	B-cell_type
cells	I-cell_type
.	O

0021-972X/97/	NULL
$	NULL
03.00/0	NULL
Journal	NULL
of	NULL
Clinical	NULL
Endocrinology	NULL
and	NULL
Metabolism	NULL
Copyright	NULL
©	NULL
1997	NULL
by	NULL
The	NULL
Endocrine	NULL
Society	NULL
Vol	NULL
.	NULL

82	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
y-Interferon-Induced	NULL
Resistance	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
Human	NULL
Monocytes	NULL
and	NULL
Macrophages	NULL
:	NULL
A	NULL
Mechanism	NULL
for	NULL
the	NULL
Hypercalcemia	NULL
of	NULL
Various	NULL
Granulomatoses*	NULL
A.S.	NULL
DUSSO	NULL
,	NULL
S.	NULL
KAMIMURA	NULL
,	NULL
M.	NULL
GALLIENI	NULL
,	NULL
M.	NULL
ZHONG	NULL
,	NULL
L.	NULL
NEGREA	NULL
,	NULL
S.	NULL
SHAPIRO	NULL
,	NULL
AND	NULL
E.	NULL
SLATOPOLSKY	NULL
The	NULL
Divisions	NULL
of	NULL
Nephrology	NULL
(	NULL
A.S.D	NULL
.	NULL

,	NULL
SK	NULL
.	NULL

,	NULL
M.G	NULL
.	NULL

,	NULL
M.Z	NULL
.	NULL

,	NULL
L.N	NULL
.	NULL

,	NULL
E.S	NULL
.	NULL
)	NULL

and	NULL
Respiratory	NULL
and	NULL
Critical	NULL
Care	NULL
(	NULL
S.S.	NULL
)	NULL
,	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Washington	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110	NULL
ABSTRACT	NULL
The	NULL
hypercalcemia	NULL
of	NULL
various	NULL
granulomatoses	NULL
is	NULL
caused	NULL
by	NULL
endogenous	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
[	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
]	NULL
overproduction	NULL
by	NULL
disease-activated	NULL
macrophages	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
its	NULL
synthesis	NULL
in	NULL
macrophages	NULL
contrasts	NULL
with	NULL
the	NULL
tight	NULL
control	NULL
of	NULL
its	NULL
production	NULL
in	NULL
macrophage	NULL
precursors	NULL
,	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
PBM	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
resistance	NULL
develops	NULL
as	NULL
PBM	NULL
differentiate	NULL
to	NULL
macrophages	NULL
or	NULL
with	NULL
macrophage	NULL
activation	NULL
.	NULL

Normal	NULL
human	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
(	NULL
PAM	NULL
)	NULL
are	NULL
less	NULL
sensitive	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
than	NULL
PBM	NULL
,	NULL
despite	NULL
similar	NULL
vitamin	NULL
D	NULL
receptor	NULL
content	NULL
;	NULL
however	NULL
,	NULL
both	NULL
PBM	NULL
and	NULL
PAM	NULL
respond	NULL
to	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
by	NULL
inhibiting	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
synthesis	NULL
and	NULL
inducing	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
degradation	NULL
through	NULL
enhancement	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
and	NULL
activity	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
mimics	NULL
PAM	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
and	NULL
sensitivity	NULL
to	NULL
exogenous	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
.	NULL

We	NULL
utilized	NULL
THP-1	NULL
cells	NULL
to	NULL
examine	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
with	NULL
macrophage	NULL
activation	NULL
.	NULL

Activation	NULL
of	NULL
THP-1	NULL
cells	NULL
with	NULL
y-interferon	NULL
(	NULL
y-IFN	NULL
)	NULL
enhances	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
30-fold	NULL
,	NULL
blocks	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
suppression	NULL
of	NULL
its	NULL
synthesis	NULL
,	NULL
and	NULL
reduces	NULL
by	NULL
42.2	NULL
%	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
its	NULL
degradation	NULL
.	NULL

The	NULL
antagonistic	NULL
effects	NULL
of	NULL
y-IFN	NULL
are	NULL
not	NULL
merely	NULL
restricted	NULL
to	NULL
enzymatic	NULL
activities	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
and	NULL
in	NULL
normal	NULL
PBM	NULL
,	NULL
y-IFN	NULL
inhibits	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
without	NULL
reducing	NULL
mRNA	NULL
stability	NULL
,	NULL
suggesting	NULL
y-IFN	NULL
inhibition	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
transactivating	NULL
function	NULL
.	NULL

These	NULL
results	NULL
explain	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
overproduction	NULL
in	NULL
granulomatoses	NULL
and	NULL
demonstrate	NULL
potent	NULL
inhibition	NULL
by	NULL
y-IFN	NULL
of	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
;	NULL
D	NULL
;	NULL
action	NULL
in	NULL
immune	NULL
cells	NULL
.	NULL

(	NULL
J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
82	NULL
:	NULL
2222-2232	NULL
,	NULL
1997	NULL
)	NULL
HE	NULL
HYPERCALCEMIA	NULL
associated	NULL
with	NULL
sarcoidosis	NULL
,	NULL
tuberculosis	NULL
,	NULL
various	NULL
granulomatoses	NULL
and	NULL
rheumatoid	NULL
arthritis	NULL
is	NULL
caused	NULL
by	NULL
endogenous	NULL
overproduction	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
[	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
]	NULL
(	NULL
1	NULL
)	NULL
,	NULL
the	NULL
most	NULL
active	NULL
metabolite	NULL
of	NULL
vitamin	NULL
D	NULL
(	NULL
2	NULL
)	NULL
,	NULL
by	NULL
the	NULL
disease	NULL
activated	NULL
macrophage	NULL
.	NULL

Under	NULL
normal	NULL
physiological	NULL
circumstances	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
is	NULL
synthesized	NULL
almost	NULL
exclusively	NULL
in	NULL
the	NULL
kidney	NULL
.	NULL

The	NULL
renal	NULL
1a-hydroxylation	NULL
of	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
is	NULL
catalyzed	NULL
by	NULL
a	NULL
cytochrome	NULL
P450-linked	NULL
mixed	NULL
function	NULL
oxidase	NULL
located	NULL
in	NULL
the	NULL
mitochon-dria	NULL
of	NULL
the	NULL
proximal	NULL
tubules	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Renal	NULL
1	NULL
«	NULL
-hydroxylase	NULL
activity	NULL
is	NULL
under	NULL
stringent	NULL
regulation	NULL
by	NULL
serum	NULL
levels	NULL
of	NULL
para-thyroid	NULL
hormone	NULL
,	NULL
calcium	NULL
,	NULL
phosphorus	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
3	NULL
itself	NULL
(	NULL
3	NULL
)	NULL
,	NULL
so	NULL
that	NULL
serum	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
levels	NULL
remain	NULL
within	NULL
the	NULL
normal	NULL
range	NULL
even	NULL
in	NULL
cases	NULL
of	NULL
vitamin	NULL
D	NULL
intoxication	NULL
in	NULL
which	NULL
circulating	NULL
250HD	NULL
;	NULL
levels	NULL
increase	NULL
70-fold	NULL
above	NULL
normal	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
sarcoidosis	NULL
and	NULL
tuberculosis	NULL
,	NULL
macrophage	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
correlates	NULL
with	NULL
250HD	NULL
;	NULL
levels	NULL
(	NULL
5	NULL
)	NULL
and	NULL
the	NULL
degree	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
in	NULL
the	NULL
host	NULL
(	NULL
6	NULL
)	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
overproduction	NULL
occurs	NULL
despite	NULL
severe	NULL
hypercalcemia	NULL
,	NULL
suppressed	NULL
PTH	NULL
levels	NULL
,	NULL
and	NULL
supranormal	NULL
Received	NULL
October	NULL
28	NULL
,	NULL
1996	NULL
.	NULL

Revision	NULL
received	NULL
January	NULL
8	NULL
,	NULL
1997	NULL
.	NULL

Re-revision	NULL
received	NULL
March	NULL
5	NULL
,	NULL
1997	NULL
.	NULL

Accepted	NULL
March	NULL
19	NULL
,	NULL
1997	NULL
.	NULL

Address	NULL
correspondence	NULL
and	NULL
requests	NULL
for	NULL
reprints	NULL
to	NULL
:	NULL
Adriana	NULL
Dusso	NULL
,	NULL
Ph.D.	NULL
,	NULL
Renal	NULL
Division	NULL
-	NULL
Department	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
660	NULL
South	NULL
Euclid	NULL
Avenue	NULL
,	NULL
Box	NULL
8126	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Missouri	NULL
63110-1093	NULL
.	NULL

*This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
U.S.	NULL
Public	NULL
Health	NULL
Service	NULL
NIADDK	NULL
Grants	NULL
DK-09976	NULL
,	NULL
DK-07126	NULL
,	NULL
HL50472	NULL
and	NULL
HL54853	NULL
.	NULL

concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggested	NULL
that	NULL
nonrenal	NULL
1	NULL
«	NULL
-hydroxylases	NULL
do	NULL
not	NULL
respond	NULL
to	NULL
the	NULL
modulators	NULL
of	NULL
the	NULL
renal	NULL
enzyme	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
studies	NULL
in	NULL
vitro	NULL
using	NULL
sarcoid	NULL
(	NULL
6	NULL
,	NULL
10	NULL
)	NULL
or	NULL
cytokine	NULL
activated	NULL
macrophages	NULL
(	NULL
11	NULL
)	NULL
demonstrated	NULL
that	NULL
the	NULL
1a-hydroxylation	NULL
reaction	NULL
is	NULL
relatively	NULL
immune	NULL
to	NULL
stimulation	NULL
by	NULL
calcium	NULL
,	NULL
PTH	NULL
,	NULL
or	NULL
to	NULL
feedback	NULL
inhibition	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

The	NULL
resistance	NULL
of	NULL
activated	NULL
macrophages	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
inhibition	NULL
of	NULL
its	NULL
own	NULL
production	NULL
contrasts	NULL
markedly	NULL
with	NULL
the	NULL
high	NULL
sensitivity	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
of	NULL
peripheral	NULL
monocytes	NULL
,	NULL
the	NULL
precursors	NULL
of	NULL
tissue	NULL
macrophages	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
renal	NULL
enzyme	NULL
,	NULL
monocyte	NULL
1la-hydroxylase	NULL
activity	NULL
is	NULL
profoundly	NULL
suppressed	NULL
by	NULL
physiological	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
vitro	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
in	NULL
vivo	NULL
as	NULL
demonstrated	NULL
in	NULL
peripheral	NULL
monocytes	NULL
from	NULL
hemo-dialysis	NULL
patients	NULL
undergoing	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
replacement	NULL
therapy	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
characterize	NULL
the	NULL
cause	NULL
of	NULL
this	NULL
discrep-ancy	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
mechanisms	NULL
involved	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
control	NULL
of	NULL
its	NULL
synthesis	NULL
in	NULL
normal	NULL
monocytes	NULL
,	NULL
and	NULL
whether	NULL
the	NULL
response	NULL
to	NULL
the	NULL
sterol	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte-macrophage	NULL
lineage	NULL
decreases	NULL
as	NULL
monocytes	NULL
differentiate	NULL
to	NULL
tissue	NULL
macrophages	NULL
or	NULL
as	NULL
a	NULL
result	NULL
of	NULL
macrophage	NULL
activation	NULL
.	NULL

An	NULL
alternative	NULL
mechanism	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
to	NULL
control	NULL
its	NULL
net	NULL
production	NULL
,	NULL
and	NULL
therefore	NULL
its	NULL
plasma	NULL
levels	NULL
in	NULL
humans	NULL
,	NULL
is	NULL
to	NULL
increase	NULL
its	NULL
metabolic	NULL
clearance	NULL
rate	NULL
(	NULL
14	NULL
)	NULL
through	NULL
the	NULL
enhancement	NULL
of	NULL
24-hydroxylase	NULL
activity	NULL
,	NULL
the	NULL
enzyme	NULL
responsible	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
inactivation	NULL
in	NULL
mammals	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
degradation	NULL
occurs	NULL
mainly	NULL
in	NULL
kidney	NULL
and	NULL
intestine	NULL
(	NULL
15-17	NULL
)	NULL
,	NULL
where	NULL
the	NULL
sterol	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
24-hydroxylase	NULL
through	NULL
a	NULL
typical	NULL
steroid-like	NULL
mechanism	NULL
2222	NULL
Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
y-INTERFERON	NULL
INHIBITION	NULL
OF	NULL
VITAMIN	NULL
D	NULL
ACTION	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binds	NULL
its	NULL
intracellular	NULL
vitamin	NULL
D	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
,	NULL
and	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-V	NULL
DR	NULL
complex	NULL
interacts	NULL
with	NULL
additional	NULL
nuclear	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
with	NULL
specific	NULL
vitamin	NULL
D	NULL
responsive	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
gene	NULL
enhancing	NULL
the	NULL
rate	NULL
of	NULL
transcription	NULL
(	NULL
20	NULL
)	NULL
.	NULL

A	NULL
discrepancy	NULL
similar	NULL
to	NULL
that	NULL
described	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
control	NULL
of	NULL
its	NULL
synthesis	NULL
also	NULL
exists	NULL
between	NULL
normal	NULL
PBM	NULL
and	NULL
disease	NULL
activated	NULL
macrophages	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-induction	NULL
of	NULL
its	NULL
degradation	NULL
.	NULL

Early	NULL
studies	NULL
utilizing	NULL
sarcoid	NULL
PAM	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
or	NULL
cytokine	NULL
activated	NULL
PAM	NULL
(	NULL
21	NULL
)	NULL
,	NULL
before	NULL
the	NULL
cloning	NULL
of	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
,	NULL
did	NULL
not	NULL
demonstrate	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
activity	NULL
even	NULL
in	NULL
response	NULL
to	NULL
concentrations	NULL
of	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
400	NULL
times	NULL
above	NULL
normal	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Inter-estingly	NULL
,	NULL
VDR	NULL
content	NULL
was	NULL
not	NULL
reduced	NULL
in	NULL
activated	NULL
macrophages	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
normal	NULL
monocytes	NULL
,	NULL
physiological	NULL
concentrations	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induce	NULL
250HD	NULL
;	NULL
(	NULL
12	NULL
,	NULL
23	NULL
)	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
degradation	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
actual	NULL
contribution	NULL
of	NULL
the	NULL
C24-oxidation	NULL
pathway	NULL
in	NULL
both	NULL
processes	NULL
in	NULL
monocytes	NULL
,	NULL
however	NULL
,	NULL
has	NULL
not	NULL
been	NULL
evaluated	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
its	NULL
degradation	NULL
in	NULL
human	NULL
monocyte-macrophages	NULL
does	NULL
not	NULL
involve	NULL
C24-hydroxylation	NULL
.	NULL

Alterna-tively	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
gene	NULL
may	NULL
be	NULL
impaired	NULL
along	NULL
monocytic	NULL
differentiation	NULL
to	NULL
macrophages	NULL
or	NULL
as	NULL
a	NULL
direct	NULL
result	NULL
of	NULL
macrophage	NULL
activation	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
mechanisms	NULL
mediating	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
resis-tance	NULL
,	NULL
first	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
involvement	NULL
of	NULL
rapid	NULL
(	NULL
non-genomic	NULL
)	NULL
and/or	NULL
steroid-like	NULL
(	NULL
genomic	NULL
)	NULL
mechanisms	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
control	NULL
of	NULL
its	NULL
production	NULL
in	NULL
PBM	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
differentiation	NULL
by	NULL
comparing	NULL
the	NULL
response	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
its	NULL
synthesis	NULL
as	NULL
well	NULL
as	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
catabolism	NULL
between	NULL
resting	NULL
peripheral	NULL
monocytes	NULL
and	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
from	NULL
normal	NULL
adults	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
that	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
constitutes	NULL
a	NULL
proper	NULL
model	NULL
of	NULL
tissue	NULL
macrophage	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
activation	NULL
of	NULL
normal	NULL
monocytes	NULL
and	NULL
THP-1	NULL
cells	NULL
with	NULL
the	NULL
cytokine	NULL
y-IFN	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
modulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
1	NULL
«	NULL
-	NULL
and	NULL
24-	NULL
hy-droxylases	NULL
,	NULL
and	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
.	NULL

We	NULL
demonstrate	NULL
the	NULL
existence	NULL
of	NULL
potent	NULL
antagonistic	NULL
effects	NULL
of	NULL
y-IFN	NULL
not	NULL
only	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
control	NULL
of	NULL
the	NULL
activities	NULL
of	NULL
1	NULL
«	NULL
-	NULL
and	NULL
24-hydroxylases	NULL
,	NULL
but	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
-induc-tion	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
latter	NULL
is	NULL
not	NULL
the	NULL
result	NULL
of	NULL
a	NULL
decreased	NULL
half	NULL
life	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
,	NULL
suggesting	NULL
that	NULL
y-IFEN	NULL
impairs	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
transactivating	NULL
function	NULL
in	NULL
normal	NULL
monocytes	NULL
and	NULL
in	NULL
THP-1	NULL
cells	NULL
leading	NULL
to	NULL
vitamin	NULL
D	NULL
resistance	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
25-hydroxy	NULL
[	NULL
26	NULL
(	NULL
27	NULL
)	NULL
-methyl	NULL
*HJcholecalciferol	NULL
,	NULL
[	NULL
specific	NULL
activity	NULL
(	NULL
S.A.	NULL
)	NULL
:	NULL
10-30	NULL
Ci/mmol	NULL
]	NULL
,	NULL
1	NULL
«	NULL
,25-hydroxy	NULL
[	NULL
26,27	NULL
methyl-*HJcholecalciferol	NULL
(	NULL
S.A.	NULL
:	NULL
130-180	NULL
Ci/mmol	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Amersham	NULL
Corporation	NULL
(	NULL
Ar-lington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
and	NULL
1,24,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Milan	NULL
Uskokovic	NULL
(	NULL
Hoffman-La	NULL
Roche	NULL
Nutely	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
1,25-dihydroxy-24-o0xo-vitamin	NULL
D	NULL
;	NULL
,	NULL
by	NULL
Dr.	NULL
G.S	NULL
.	NULL

Reddy	NULL
(	NULL
Women	NULL
and	NULL
Infants	NULL
Hospital	NULL
,	NULL
Providence	NULL
,	NULL
RI	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
y-interferon	NULL
(	NULL
S.	NULL
A.	NULL
:	NULL
20-40	NULL
million	NULL
IU/ml	NULL
)	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Genentech	NULL
(	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

2223	NULL
Cell	NULL
culture	NULL
Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
volunteers	NULL
using	NULL
a	NULL
Ficoll-Paque	NULL
gradient	NULL
(	NULL
Pharmacia	NULL
LKB	NULL
Biotechnology	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
processed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
12	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
six-well	NULL
plates	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
``	NULL
cells/well	NULL
in	NULL
1	NULL
mL	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

After	NULL
an	NULL
18	NULL
h	NULL
incubation	NULL
at	NULL
37	NULL
C	NULL
in	NULL
humidified	NULL
95	NULL
%	NULL
air	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
nonadherent	NULL
cells	NULL
and	NULL
medium	NULL
were	NULL
removed	NULL
.	NULL

More	NULL
than	NULL
95	NULL
%	NULL
of	NULL
these	NULL
adherent	NULL
cells	NULL
stained	NULL
positively	NULL
for	NULL
e-naphthyl	NULL
esterase	NULL
,	NULL
a	NULL
specific	NULL
marker	NULL
for	NULL
cells	NULL
of	NULL
the	NULL
monocyte-macrophage	NULL
lineage	NULL
(	NULL
25	NULL
)	NULL
.	NULL

The	NULL
adherent	NULL
cell	NULL
population	NULL
was	NULL
used	NULL
in	NULL
all	NULL
studies	NULL
.	NULL

Human	NULL
alveolar	NULL
macrophages	NULL
were	NULL
isolated	NULL
from	NULL
healthy	NULL
adult	NULL
volunteers	NULL
by	NULL
saline	NULL
bronchoalveolar	NULL
lavage	NULL
using	NULL
a	NULL
protocol	NULL
approved	NULL
by	NULL
the	NULL
Human	NULL
Study	NULL
Committee	NULL
at	NULL
Washington	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Macrophages	NULL
were	NULL
plated	NULL
in	NULL
1	NULL
mL	NULL
of	NULL
Hank	NULL
's	NULL
balanced	NULL
salt	NULL
solution	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10°	NULL
cells	NULL
per	NULL
well	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
C	NULL
to	NULL
allow	NULL
attachment	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
then	NULL
replaced	NULL
with	NULL
1	NULL
mL	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
C	NULL
in	NULL
humidified	NULL
95	NULL
%	NULL
air	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
for	NULL
18	NULL
h	NULL
before	NULL
use	NULL
.	NULL

The	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
Beth	NULL
Lee	NULL
,	NULL
Renal	NULL
Division	NULL
,	NULL
Washington	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
was	NULL
grown	NULL
in	NULL
suspension	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
and	NULL
induced	NULL
to	NULL
acquire	NULL
a	NULL
macrophage	NULL
phenotype	NULL
(	NULL
28	NULL
)	NULL
by	NULL
exposure	NULL
to	NULL
160	NULL
nmol/L	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
24	NULL
h	NULL
in	NULL
six-well	NULL
plates	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells/well	NULL
.	NULL

The	NULL
medium	NULL
was	NULL
then	NULL
exchanged	NULL
for	NULL
1	NULL
mL	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
and	NULL
the	NULL
adherent	NULL
,	NULL
phorbol	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
(	NULL
dTHP-1	NULL
cells	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
C	NULL
in	NULL
humidified	NULL
95	NULL
%	NULL
air	NULL
,	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
,	NULL
for	NULL
18	NULL
h	NULL
before	NULL
use	NULL
.	NULL

Time	NULL
course	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
vitamin	NULL
D	NULL
metabolism	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
Normal	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
plated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
(	NULL
Control	NULL
)	NULL
or	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
h.	NULL
Medium	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
and	NULL
twice	NULL
with	NULL
incubation	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
)	NULL
to	NULL
remove	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

The	NULL
rates	NULL
of	NULL
conversion	NULL
of	NULL
tritiated	NULL
250HD	NULL
;	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
to	NULL
metabolites	NULL
more	NULL
polar	NULL
than	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
(	NULL
polar	NULL
metabolites	NULL
)	NULL
were	NULL
measured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
control	NULL
values	NULL
(	NULL
untreated	NULL
monocytes	NULL
)	NULL
for	NULL
both	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
inhibition	NULL
of	NULL
its	NULL
synthesis	NULL
and	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
catabolic	NULL
pathways	NULL
.	NULL

For	NULL
each	NULL
time	NULL
point	NULL
,	NULL
determinations	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
hydroxylation	NULL
pathway	NULL
induced	NULL
by	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
,	NULL
polar	NULL
metabolites	NULL
synthesized	NULL
by	NULL
untreated	NULL
monocytes	NULL
and	NULL
by	NULL
monocytes	NULL
exposed	NULL
to	NULL
0.24	NULL
nmol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
for	NULL
18	NULL
h	NULL
were	NULL
extracted	NULL
,	NULL
dried	NULL
under	NULL
nitrogen	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
500	NULL
gL	NULL
of	NULL
8	NULL
%	NULL
sodium	NULL
periodate	NULL
(	NULL
NaIO	NULL
,	NULL
)	NULL
,	NULL
200	NULL
LL	NULL
K	NULL
,	NULL
PO	NULL
,	NULL
,	NULL
10	NULL
mmol/L	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
and	NULL
300	NULL
ul	NULL
acetic	NULL
acid	NULL
0.1	NULL
mol/L	NULL
for	NULL
30	NULL
min	NULL
at	NULL
0-4	NULL
C	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
,	NULL
1	NULL
mL	NULL
acetonitrile	NULL
and	NULL
0.5	NULL
mL	NULL
of	NULL
0.4	NULL
mol/L	NULL
K	NULL
,	NULL
HPO	NULL
,	NULL
(	NULL
pH	NULL
=	NULL
10.6	NULL
)	NULL
were	NULL
added	NULL
,	NULL
samples	NULL
were	NULL
centrifuged	NULL
at	NULL
2,5008	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
subsequently	NULL
re-extracted	NULL
using	NULL
C-18	NULL
cartridges	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
polar	NULL
metabolites	NULL
,	NULL
we	NULL
performed	NULL
normal	NULL
phase	NULL
high	NULL
performance	NULL
liquid	NULL
chromatography	NULL
(	NULL
HPLC	NULL
)	NULL
on	NULL
the	NULL
acetonitrile	NULL
fraction	NULL
using	NULL
2.7	NULL
%	NULL
isopropanol	NULL
in	NULL
methylene	NULL
chloride	NULL
as	NULL
the	NULL
mobile	NULL
phase	NULL
and	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
2	NULL
mL/min	NULL
.	NULL

The	NULL
retention	NULL
times	NULL
of	NULL
24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
1,25-	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
1,24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
-24-o0xo-vitamin	NULL
D	NULL
;	NULL
,	NULL
standards	NULL
were	NULL
3.6	NULL
,	NULL
10.2	NULL
,	NULL
16.0	NULL
,	NULL
and	NULL
9.9	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
2-min	NULL
methanol	NULL
strip	NULL
of	NULL
the	NULL
column	NULL
followed	NULL
the	NULL
elution	NULL
of	NULL
the	NULL
1,24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
peak	NULL
.	NULL

HPLC	NULL
fractions	NULL
of	NULL
tritiated	NULL
metabolites	NULL
eluting	NULL
with	NULL
nonradioactive	NULL
standards	NULL
and	NULL
with	NULL
methanol	NULL
were	NULL
collected	NULL
and	NULL
counted	NULL
for	NULL
tritium	NULL
.	NULL

Results	NULL
were	NULL
compared	NULL
to	NULL
control	NULL
samples	NULL
run	NULL
in	NULL
parallel	NULL
but	NULL
not	NULL
subjected	NULL
to	NULL
NaIO	NULL
,	NULL
treatment	NULL
.	NULL

Role	NULL
of	NULL
new	NULL
protein	NULL
synthesis	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
by	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
;	NULL
Monocytes	NULL
were	NULL
co-incubated	NULL
with	NULL
0	NULL
or	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
0	NULL
or	NULL
0.1	NULL
ug/ml	NULL
cycloheximide	NULL
for	NULL
4	NULL
h	NULL
at	NULL
37	NULL
C	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
albumin	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
this	NULL
incubation	NULL
,	NULL
cells	NULL
Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
2224	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
once	NULL
with	NULL
incubation	NULL
medium	NULL
.	NULL

The	NULL
rate	NULL
of	NULL
conversion	NULL
of	NULL
tritiated	NULL
250HD	NULL
;	NULL
to	NULL
polar	NULL
metabolites	NULL
was	NULL
measured	NULL
in	NULL
triplicate	NULL
for	NULL
each	NULL
experimental	NULL
condition	NULL
,	NULL
as	NULL
described	NULL
(	NULL
12	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
expressed	NULL
as	NULL
percent	NULL
over	NULL
the	NULL
rate	NULL
of	NULL
synthesis	NULL
of	NULL
polar	NULL
metabolite	NULL
by	NULL
untreated	NULL
monocytes	NULL
.	NULL

Time	NULL
course	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
normal	NULL
monocytes	NULL
Monocytes	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
and	NULL
0	NULL
or	NULL
0.24	NULL
nmol	NULL
/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
or	NULL
18	NULL
h.	NULL
Medium	NULL
was	NULL
then	NULL
removed	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
washed	NULL
with	NULL
2	NULL
mL	NULL
PBS	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
using	NULL
RNAzol	NULL
(	NULL
Tele	NULL
Test	NULL
Inc.	NULL
,	NULL
Friendswood	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydro-genase	NULL
(	NULL
GAPDH	NULL
)	NULL
mRNA	NULL
levels	NULL
using	NULL
the	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
dissolved	NULL
in	NULL
4	NULL
gL	NULL
of	NULL
diethyl	NULL
pyrocarbonate	NULL
water	NULL
and	NULL
mixed	NULL
with	NULL
26	NULL
pL	NULL
hybridization	NULL
buffer	NULL
(	NULL
80	NULL
%	NULL
formamide	NULL
,	NULL
50	NULL
mmol/L	NULL
PIPES	NULL
,	NULL
pH	NULL
=	NULL
6.4	NULL
,	NULL
400	NULL
mnol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
)	NULL
containing	NULL
*°P	NULL
labeled	NULL
riboprobes	NULL
for	NULL
human	NULL
24-hydroxylase	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
.	NULL

After	NULL
hybridization	NULL
at	NULL
45	NULL
C	NULL
for	NULL
16	NULL
h	NULL
,	NULL
samples	NULL
were	NULL
mixed	NULL
with	NULL
150	NULL
uL	NULL
ribonuclease	NULL
digestion	NULL
mixture	NULL
containing	NULL
2	NULL
ug	NULL
ribonuclease	NULL
T1	NULL
in	NULL
10	NULL
mmol/L	NULL
Tris-HCI	NULL
,	NULL
pH	NULL
5.0	NULL
,	NULL
300	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
37	NULL
C.	NULL
Proteinase	NULL
K	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
and	NULL
20	NULL
uL	NULL
of	NULL
5	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
were	NULL
then	NULL
added	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
additional	NULL
minutes	NULL
.	NULL

Following	NULL
phenolchloroform	NULL
extraction	NULL
and	NULL
ethanol	NULL
pre-cipitation	NULL
,	NULL
samples	NULL
were	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrilamide	NULL
gel	NULL
.	NULL

Bands	NULL
in	NULL
the	NULL
dried	NULL
gel	NULL
were	NULL
quantified	NULL
by	NULL
scanning	NULL
densitometry	NULL
after	NULL
a	NULL
48	NULL
h-exposure	NULL
using	NULL
a	NULL
PhosphorImager	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Riboprobes..	NULL

The	NULL
human	NULL
24-hydroxylase	NULL
template	NULL
is	NULL
the	NULL
BamHI	NULL
restriction	NULL
fragment	NULL
,	NULL
bases	NULL
1657	NULL
to	NULL
1999	NULL
of	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
complementary	NULL
(	NULL
c	NULL
)	NULL
DNA	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
H.	NULL
DeLuca	NULL
,	NULL
University	NULL
of	NULL
Wiscon-sin	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
subcloned	NULL
into	NULL
Bluescript	NULL
KS	NULL
(	NULL
Stratagen	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
template	NULL
for	NULL
human	NULL
GAPDH	NULL
was	NULL
purchased	NULL
from	NULL
Ambion	NULL
(	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

For	NULL
both	NULL
templates	NULL
,	NULL
radiolabeled	NULL
antisense	NULL
riboprobes	NULL
were	NULL
produced	NULL
using	NULL
RNA	NULL
polymerase	NULL
T7	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
protected	NULL
fragments	NULL
was	NULL
342	NULL
bp	NULL
for	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
and	NULL
150	NULL
for	NULL
the	NULL
human	NULL
GAPDH	NULL
.	NULL

1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
;	NULL
synthesis	NULL
and	NULL
the	NULL
response	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
;	NULL
in	NULL
tissue	NULL
macrophages	NULL
PAM	NULL
and	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
albumin	NULL
RPMI	NULL
1640	NULL
with	NULL
0	NULL
,	NULL
0.24	NULL
,	NULL
4.8	NULL
,	NULL
12	NULL
,	NULL
or	NULL
24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
4	NULL
or	NULL
18	NULL
h	NULL
,	NULL
as	NULL
indicated	NULL
for	NULL
each	NULL
experimental	NULL
protocol	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
these	NULL
incu-bations	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
and	NULL
of	NULL
polar	NULL
metabolites	NULL
was	NULL
measured	NULL
in	NULL
triplicate	NULL
for	NULL
each	NULL
dose	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
tested	NULL
,	NULL
as	NULL
described	NULL
for	NULL
PBM	NULL
.	NULL

To	NULL
quantitate	NULL
mRNA	NULL
levels	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
three	NULL
individual	NULL
wells	NULL
of	NULL
cells	NULL
for	NULL
each	NULL
experimental	NULL
condition	NULL
and	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
using	NULL
the	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
described	NULL
above	NULL
.	NULL

Vitamin	NULL
D	NULL
receptor	NULL
content	NULL
To	NULL
assess	NULL
VDR	NULL
content	NULL
,	NULL
PBM	NULL
,	NULL
PAM	NULL
,	NULL
and	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
0.26	NULL
nmol/L	NULL
[	NULL
PH	NULL
]	NULL
-1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37	NULL
C	NULL
,	NULL
with	NULL
(	NULL
nonspecific	NULL
binding	NULL
)	NULL
or	NULL
without	NULL
125	NULL
nmol/L	NULL
radioinert	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

Maximal	NULL
specific	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
binding	NULL
to	NULL
the	NULL
VDR	NULL
was	NULL
measured	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
rinsed	NULL
with	NULL
PBS	NULL
containing	NULL
5	NULL
mg/ml	NULL
albumin	NULL
,	NULL
placed	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
sonicated	NULL
for	NULL
30	NULL
sec	NULL
in	NULL
2	NULL
mL	NULL
TEDK	NULL
buffer	NULL
.	NULL

Free	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
was	NULL
separated	NULL
from	NULL
the	NULL
bound	NULL
sterol	NULL
using	NULL
dextran-charcoal	NULL
,	NULL
and	NULL
tritium	NULL
was	NULL
counted	NULL
in	NULL
the	NULL
supernatant	NULL
.	NULL

Effect	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
in	NULL
dTHP-1	NULL
cells	NULL
THP-1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
160	NULL
nmol/L	NULL
TPA	NULL
in	NULL
10	NULL
%	NULL
FBS	NULL
RPMI	NULL
1640	NULL
for	NULL
24	NULL
h.	NULL
dTHP-1	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
once	NULL
with	NULL
serum	NULL
free	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
,	NULL
and	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
BSA	NULL
and	NULL
0	NULL
or	NULL
2000	NULL
IU/mL	NULL
y-IFN	NULL
for	NULL
18	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
washed	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
synthesis	NULL
was	NULL
measured	NULL
as	NULL
DUSSO	NULL
ET	NULL
AL	NULL
.	NULL

JCE	NULL
&	NULL
M	NULL
»	NULL
1997	NULL
Vol	NULL
82	NULL
«	NULL
No	NULL
7	NULL
described	NULL
for	NULL
PBM	NULL
.	NULL

For	NULL
Km	NULL
and	NULL
Vmax	NULL
determinations	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
was	NULL
measured	NULL
in	NULL
triplicate	NULL
using	NULL
four	NULL
different	NULL
concentrations	NULL
of	NULL
250HD	NULL
;	NULL
(	NULL
from	NULL
5	NULL
to	NULL
300	NULL
nm	NULL
)	NULL
.	NULL

1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
was	NULL
measured	NULL
in	NULL
triplicate	NULL
for	NULL
every	NULL
substrate	NULL
concentration	NULL
;	NULL
Km	NULL
and	NULL
Vmax	NULL
were	NULL
obtained	NULL
from	NULL
a	NULL
linear	NULL
regression	NULL
analysis	NULL
of	NULL
the	NULL
data	NULL
using	NULL
the	NULL
double	NULL
reciprocal	NULL
plot	NULL
of	NULL
Lineweaver-Burk	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
1a-hydroxylation	NULL
of	NULL
250HD	NULL
;	NULL
in	NULL
dTHP-1	NULL
cells	NULL
was	NULL
mediated	NULL
by	NULL
a	NULL
cytochrome	NULL
P450-linked	NULL
mixed	NULL
function	NULL
oxidase	NULL
,	NULL
or	NULL
by	NULL
nonenzymatic	NULL
oxidation	NULL
of	NULL
250HD	NULL
;	NULL
by	NULL
free	NULL
radicals	NULL
(	NULL
generated	NULL
through	NULL
the	NULL
activation	NULL
of	NULL
macrophages	NULL
by	NULL
y-IFN	NULL
)	NULL
,	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
or	NULL
2000	NULL
IU/mL	NULL
y-IFN	NULL
for	NULL
18	NULL
h	NULL
as	NULL
indicated	NULL
for	NULL
Km	NULL
and	NULL
Vmax	NULL
determinations	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
medium	NULL
was	NULL
replaced	NULL
by	NULL
0.1	NULL
%	NULL
BSA-	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
umol/L	NULL
ketoconazole	NULL
,	NULL
a	NULL
cytochrome	NULL
P450	NULL
inhibitor	NULL
,	NULL
or	NULL
the	NULL
free	NULL
radical	NULL
scavengers	NULL
N	NULL
,	NULL
N'-diphenylethylenediamine	NULL
(	NULL
10	NULL
mol/L	NULL
)	NULL
or	NULL
ethylendiaminetetrace-tic	NULL
acid	NULL
(	NULL
3	NULL
mmol/L	NULL
)	NULL
.	NULL

For	NULL
each	NULL
experimental	NULL
condition	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
was	NULL
measured	NULL
in	NULL
triplicate	NULL
.	NULL

We	NULL
assessed	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
generated	NULL
by	NULL
THP-1	NULL
cells	NULL
as	NULL
follows	NULL
:	NULL
Nonadherent	NULL
THP-1	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
eight	NULL
tissue	NULL
culture	NULL
dishes	NULL
(	NULL
60	NULL
X	NULL
15	NULL
mmol/L	NULL
)	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
6	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
3	NULL
ml	NULL
10	NULL
%	NULL
FBS	NULL
RPMI	NULL
1640	NULL
containing	NULL
160	NULL
nmol/L	NULL
TPA	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37	NULL
C	NULL
for	NULL
24	NULL
h.	NULL
Medium	NULL
was	NULL
then	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
3	NULL
mL	NULL
fresh	NULL
serum	NULL
free	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
.	NULL

1000	NULL
U/mL	NULL
y-IFN	NULL
were	NULL
then	NULL
added	NULL
to	NULL
four	NULL
of	NULL
the	NULL
dishes	NULL
.	NULL

Control	NULL
(	NULL
untreated	NULL
)	NULL
and	NULL
y-IFN-treated	NULL
dishes	NULL
were	NULL
incubated	NULL
at	NULL
37	NULL
C	NULL
for	NULL
18	NULL
h.	NULL
Medium	NULL
was	NULL
then	NULL
removed	NULL
and	NULL
replaced	NULL
with	NULL
fresh	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.5	NULL
%	NULL
BSA	NULL
.	NULL

Substrate	NULL
was	NULL
50	NULL
nmol/L	NULL
radioinert	NULL
250HD	NULL
;	NULL
in	NULL
half	NULL
of	NULL
the	NULL
control	NULL
and	NULL
y-IFEN	NULL
treated	NULL
culture	NULL
dishes	NULL
and	NULL
12	NULL
nmol/L	NULL
°H-	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
D	NULL
;	NULL
in	NULL
the	NULL
remnant	NULL
half	NULL
.	NULL

Reactions	NULL
were	NULL
stopped	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
3	NULL
mL	NULL
acetonitrile	NULL
after	NULL
a	NULL
4	NULL
or	NULL
6	NULL
h	NULL
incubation	NULL
at	NULL
37	NULL
C.	NULL
To	NULL
quantitate	NULL
recoveries	NULL
,	NULL
1000	NULL
cpm	NULL
°H-1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
were	NULL
then	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
dishes	NULL
incubated	NULL
with	NULL
radioinert	NULL
250HD	NULL
;	NULL
,	NULL
and	NULL
100	NULL
ng	NULL
radioinert	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
those	NULL
dishes	NULL
in	NULL
which	NULL
radioactive	NULL
substrate	NULL
was	NULL
used	NULL
.	NULL

Vitamin	NULL
D	NULL
metabolites	NULL
were	NULL
then	NULL
extracted	NULL
from	NULL
all	NULL
culture	NULL
dishes	NULL
using	NULL
C18	NULL
cartridges	NULL
according	NULL
to	NULL
Reinhardt	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
and	NULL
further	NULL
purified	NULL
by	NULL
straight	NULL
phase	NULL
HPLC	NULL
using	NULL
methylene	NULL
chloride	NULL
:	NULL
isopropanol	NULL
(	NULL
96:4	NULL
)	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
2	NULL
mL/min	NULL
.	NULL

Radioinert	NULL
24,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
standards	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
were	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
retention	NULL
times	NULL
for	NULL
both	NULL
metabolites	NULL
in	NULL
control	NULL
and	NULL
y-IFN	NULL
treated	NULL
cultures	NULL
dishes	NULL
.	NULL

One	NULL
min	NULL
fractions	NULL
were	NULL
collected	NULL
and	NULL
counted	NULL
for	NULL
tritium	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
putative	NULL
°H-1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesized	NULL
in	NULL
4	NULL
h	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
(	NULL
12	NULL
,	NULL
23	NULL
)	NULL
,	NULL
and	NULL
this	NULL
rate	NULL
of	NULL
synthesis	NULL
was	NULL
used	NULL
to	NULL
estimate	NULL
the	NULL
expected	NULL
concentration	NULL
of	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesized	NULL
by	NULL
dTHP-1	NULL
cells	NULL
incubated	NULL
with	NULL
radioinert	NULL
substrate	NULL
.	NULL

In	NULL
these	NULL
samples	NULL
,	NULL
the	NULL
putative	NULL
1,25	NULL
(	NULL
0OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
fractions	NULL
co-eluting	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
standards	NULL
(	NULL
retention	NULL
time	NULL
:	NULL
11.3	NULL
min	NULL
)	NULL
in	NULL
the	NULL
first	NULL
HPLC	NULL
purification	NULL
(	NULL
methylenechloride	NULL
:	NULL
isopropanol	NULL
)	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
two	NULL
additional	NULL
HPLC	NULL
purifications	NULL
:	NULL
a	NULL
straight	NULL
phase	NULL
using	NULL
hexane	NULL
:	NULL
iso-propanol	NULL
(	NULL
88:12	NULL
)	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
1.8	NULL
mL/min	NULL
(	NULL
retention	NULL
time	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
:	NULL
9.15	NULL
min	NULL
)	NULL
,	NULL
and	NULL
a	NULL
reverse	NULL
phase	NULL
HPLC	NULL
using	NULL
methanol	NULL
:	NULL
water	NULL
(	NULL
87:13	NULL
)	NULL
at	NULL
a	NULL
flow	NULL
rate	NULL
of	NULL
2	NULL
mL/min	NULL
(	NULL
retention	NULL
time	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
:	NULL
13.7	NULL
min	NULL
)	NULL
.	NULL

The	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
fraction	NULL
was	NULL
dried	NULL
under	NULL
nitrogen	NULL
,	NULL
redissolved	NULL
in	NULL
200	NULL
uL	NULL
ethanol	NULL
,	NULL
and	NULL
50	NULL
uL	NULL
were	NULL
counted	NULL
for	NULL
tritium	NULL
to	NULL
quantitate	NULL
recoveries	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
expected	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
;	NULL
concentration	NULL
and	NULL
recoveries	NULL
,	NULL
2	NULL
sets	NULL
of	NULL
dilutions	NULL
(	NULL
1:100	NULL
and	NULL
1:200	NULL
)	NULL
were	NULL
prepared	NULL
for	NULL
controls	NULL
and	NULL
y-IFN	NULL
treated	NULL
samples	NULL
.	NULL

These	NULL
dilutions	NULL
were	NULL
then	NULL
used	NULL
to	NULL
test	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
HPLC-purified	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
displace	NULL
°H-1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
from	NULL
its	NULL
binding	NULL
to	NULL
the	NULL
calf	NULL
thymus	NULL
receptor	NULL
compared	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
standards	NULL
(	NULL
1	NULL
to	NULL
20	NULL
pg/25	NULL
ul	NULL
.	NULL

ethanol	NULL
)	NULL
using	NULL
the	NULL
ra-dioreceptor	NULL
assay	NULL
of	NULL
Reinhardt	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
measured	NULL
24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
induced	NULL
by	NULL
the	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
generated	NULL
endogenously	NULL
by	NULL
THP-1	NULL
cells	NULL
from	NULL
°H-250HD	NULL
;	NULL
in	NULL
4	NULL
and	NULL
6	NULL
h.	NULL
°H-24,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
methodology	NULL
described	NULL
for	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
or	NULL
polar	NULL
metabolite	NULL
determinations	NULL
.	NULL

Effect	NULL
of	NULL
y-IFN	NULL
on	NULL
the	NULL
response	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
dTHP-1	NULL
cells	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
albumin	NULL
,	NULL
0	NULL
or	NULL
4.8	NULL
nmol	NULL
/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
and	NULL
0	NULL
or	NULL
2000	NULL
IU	NULL
/mL	NULL
y-IFN	NULL
at	NULL
37	NULL
C	NULL
for	NULL
18	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
for	NULL
PBM	NULL
and	NULL
PAM	NULL
.	NULL

To	NULL
directly	NULL
assess	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
mediated	NULL
induction	NULL
of	NULL
its	NULL
own	NULL
catabolism	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
rate	NULL
of	NULL
degradation	NULL
of	NULL
°H-1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
y-INTERFERON	NULL
INHIBITION	NULL
OF	NULL
VITAMIN	NULL
D	NULL
ACTION	NULL
Dose	NULL
response	NULL
to	NULL
y-IFN	NULL
inhibition	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
or	NULL
9.6	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
y-IFN	NULL
(	NULL
from	NULL
0	NULL
to	NULL
2000	NULL
IU/ml	NULL
!	NULL
)	NULL

for	NULL
18	NULL
h	NULL
in	NULL
serum	NULL
free	NULL
RPMI	NULL
1640	NULL
containing	NULL
1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
BSA	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
using	NULL
the	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

VDR	NULL
content	NULL
was	NULL
measured	NULL
after	NULL
an	NULL
18	NULL
h	NULL
exposure	NULL
in	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
0	NULL
,	NULL
25	NULL
,	NULL
100	NULL
,	NULL
or	NULL
2000	NULL
IU/mL	NULL
.	NULL

For	NULL
each	NULL
dose	NULL
of	NULL
the	NULL
cytokine	NULL
,	NULL
VDR	NULL
measurements	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
from	NULL
2	NULL
independent	NULL
experiments	NULL
.	NULL

Effect	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
Dy-actions	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
Peripheral	NULL
monocytes	NULL
from	NULL
normal	NULL
volunteers	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
or	NULL
0.24	NULL
nmol	NULL
/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0	NULL
or	NULL
2000	NULL
IU/mL	NULL
y-IFN	NULL
for	NULL
18	NULL
h	NULL
at	NULL
37	NULL
C	NULL
in	NULL
serum-free	NULL
(	NULL
1	NULL
%	NULL
BSA	NULL
)	NULL
RPMI	NULL
1640	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
washed	NULL
,	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
was	NULL
measured	NULL
in	NULL
cells	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
0.1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
albumin	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
prepared	NULL
from	NULL
three	NULL
individual	NULL
wells	NULL
of	NULL
monocytes	NULL
for	NULL
each	NULL
experimental	NULL
condition	NULL
and	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
as	NULL
described	NULL
.	NULL

Determinations	NULL
of	NULL
1a-hydroxylase	NULL
activity	NULL
and	NULL
mRNA	NULL
levels	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Effect	NULL
of	NULL
y-IFN	NULL
on	NULL
the	NULL
half	NULL
life	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
dTHP-1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
9.6	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
and	NULL
0	NULL
or	NULL
20	NULL
U/mL	NULL
y-IFN	NULL
.	NULL

After	NULL
an	NULL
18	NULL
h	NULL
incubation	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
RNA	NULL
polymerase	NULL
II	NULL
inhibitor	NULL
actinomycin	NULL
D	NULL
were	NULL
added	NULL
to	NULL
block	NULL
further	NULL
transcription	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
untreated	NULL
and	NULL
y-IFN	NULL
treated	NULL
cells	NULL
was	NULL
prepared	NULL
at	NULL
times	NULL
of	NULL
0	NULL
,	NULL
and	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
or	NULL
6	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D.	NULL
24-hydroxylase	NULL
,	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
were	NULL
quantitated	NULL
by	NULL
ribonuclease	NULL
protection	NULL
assay	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
single	NULL
exponential	NULL
decay	NULL
of	NULL
the	NULL
24-hydroxylase/	NULL
GAPDH	NULL
ratio	NULL
in	NULL
untreated	NULL
and	NULL
y-IFN-treated	NULL
dTHP-1	NULL
cells	NULL
,	NULL
the	NULL
half	NULL
life	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
was	NULL
calculated	NULL
as	NULL
In	NULL
2/slope	NULL
of	NULL
the	NULL
linear	NULL
regression	NULL
of	NULL
In	NULL
(	NULL
24-hydroxylase/GAPDH	NULL
mRNA	NULL
ratio	NULL
)	NULL
vs.	NULL
time	NULL
(	NULL
h	NULL
)	NULL
.	NULL

Statistics	NULL
Data	NULL
are	NULL
expressed	NULL
as	NULL
mean	NULL
+	NULL
sem	NULL
.	NULL

The	NULL
symbol	NULL
(	NULL
n	NULL
=	NULL
)	NULL
refers	NULL
to	NULL
the	NULL
number	NULL
of	NULL
independent	NULL
experiments	NULL
performed	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
one	NULL
tailed	NULL
unpaired	NULL
nonparametric	NULL
Mann-Whitney	NULL
Two	NULL
Sample	NULL
Test	NULL
or	NULL
one	NULL
way	NULL
ANOVA	NULL
for	NULL
multiple	NULL
comparisons	NULL
.	NULL

Paired	NULL
t	NULL
test	NULL
was	NULL
employed	NULL
when	NULL
comparing	NULL
results	NULL
before	NULL
and	NULL
after	NULL
treatment	NULL
in	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
.	NULL

Results	NULL
Mechanisms	NULL
mediating	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
;	NULL
regulation	NULL
of	NULL
vitamin	NULL
D	NULL
metabolism	NULL
in	NULL
normal	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Because	NULL
the	NULL
resistance	NULL
of	NULL
activated	NULL
macrophages	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-inhibition	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
is	NULL
unrelated	NULL
to	NULL
changes	NULL
in	NULL
VDR	NULL
content	NULL
,	NULL
we	NULL
first	NULL
examined	NULL
whether	NULL
the	NULL
tight	NULL
control	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
in	NULL
normal	NULL
monocytes	NULL
involved	NULL
rapid	NULL
,	NULL
nongenomic	NULL
mechanisms	NULL
instead	NULL
of	NULL
the	NULL
most	NULL
common	NULL
steroid-like	NULL
action	NULL
mediated	NULL
by	NULL
the	NULL
VDR	NULL
.	NULL

Figure	NULL
1	NULL
depicts	NULL
the	NULL
time	NULL
course	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
physiological	NULL
concentrations	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
(	NULL
0.24	NULL
nmol/L	NULL
)	NULL
on	NULL
vitamin	NULL
D	NULL
metabolism	NULL
in	NULL
peripheral	NULL
monocytes	NULL
.	NULL

Both	NULL
effects	NULL
of	NULL
the	NULL
sterol	NULL
,	NULL
the	NULL
suppression	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
catabolic	NULL
pathways	NULL
,	NULL
measured	NULL
by	NULL
the	NULL
rate	NULL
of	NULL
synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
,	NULL
were	NULL
only	NULL
evident	NULL
after	NULL
2	NULL
h.	NULL
In	NULL
four	NULL
independent	NULL
experiments	NULL
,	NULL
the	NULL
sterol	NULL
was	NULL
unable	NULL
to	NULL
reduce	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
or	NULL
to	NULL
enhance	NULL
the	NULL
generation	NULL
of	NULL
polar	NULL
metabolites	NULL
by	NULL
PBM	NULL
in	NULL
10	NULL
,	NULL
20	NULL
,	NULL
40	NULL
,	NULL
or	NULL
60	NULL
min	NULL
,	NULL
even	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
as	NULL
high	NULL
as	NULL
0.96	NULL
nmol/L	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
because	NULL
the	NULL
1a-hydroxylase	NULL
has	NULL
not	NULL
been	NULL
purified	NULL
to	NULL
homogeneity	NULL
or	NULL
cloned	NULL
,	NULL
we	NULL
could	NULL
not	NULL
con	NULL
2225	NULL
A	NULL
)	NULL
Synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
(	NULL
%	NULL
over	NULL
control	NULL
)	NULL
Synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
0.5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

Time	NULL
course	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
0.24	NULL
nmol/L	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
on	NULL
A	NULL
)	NULL
Synthesis	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
and	NULL
B	NULL
)	NULL
Synthesis	NULL
of	NULL
metabolites	NULL
more	NULL
polar	NULL
than	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
(	NULL
polar	NULL
metabolites	NULL
)	NULL
by	NULL
PBM	NULL
.	NULL

Values	NULL
for	NULL
each	NULL
time	NULL
point	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
triplicate	NULL
determinations	NULL
and	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
of	NULL
control	NULL
(	NULL
untreated	NULL
monocytes	NULL
)	NULL
.	NULL

*	NULL
and	NULL
**	NULL
indicates	NULL
P	NULL
=	NULL
0.05	NULL
and	NULL
0.001	NULL
from	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

firm	NULL
the	NULL
actual	NULL
involvement	NULL
of	NULL
genomic	NULL
mechanisms	NULL
in	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
suppression	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
in	NULL
PBM	NULL
.	NULL

We	NULL
therefore	NULL
focused	NULL
on	NULL
characterizing	NULL
whether	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
its	NULL
own	NULL
catabolism	NULL
in	NULL
monocytes	NULL
involved	NULL
a	NULL
genomic	NULL
mechanism	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
C24-hydroxylation	NULL
pathway	NULL
,	NULL
the	NULL
major	NULL
catabolic	NULL
pathway	NULL
induced	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
through	NULL
a	NULL
classical	NULL
steroid-like	NULL
mechanism	NULL
in	NULL
kidney	NULL
and	NULL
intestine	NULL
in	NULL
mammals	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Figure	NULL
2	NULL
demonstrates	NULL
the	NULL
results	NULL
of	NULL
time	NULL
course	NULL
studies	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
by	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

Under	NULL
basal	NULL
conditions	NULL
(	NULL
untreated	NULL
monocytes	NULL
)	NULL
,	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
were	NULL
undetect-able	NULL
.	NULL

Incubation	NULL
of	NULL
PBM	NULL
with	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induced	NULL
24-hydroxylase	NULL
mRNA	NULL
to	NULL
detectable	NULL
levels	NULL
after	NULL
a	NULL
2-h	NULL
exposure	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
was	NULL
linear	NULL
with	NULL
time	NULL
up	NULL
to	NULL
8	NULL
h	NULL
and	NULL
paralleled	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
3	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
,	NULL
measured	NULL
by	NULL
the	NULL
synthe-	NULL
Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
2226	NULL
24-hydroxylase	NULL
w	NULL
»	NULL
UD	NULL
GAPDH	NULL
w	NULL
his	NULL
oue	NULL
dlt	NULL
wt	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
_s	NULL
_s	NULL
o	NULL
&	NULL
n	NULL
24-hydroxylase/	NULL
GAPDH	NULL
mRNA	NULL
&	NULL
n	NULL
Time	NULL
(	NULL
hours	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
control	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
and	NULL
cells	NULL
exposed	NULL
to	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
T	NULL
)	NULL
for	NULL
0.5	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
8	NULL
h	NULL
was	NULL
assayed	NULL
for	NULL
mRNA	NULL
levels	NULL
of	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
.	NULL

A	NULL
)	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
protected	NULL
fragments	NULL
in	NULL
monocytes	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
;	NULL
B	NULL
)	NULL
Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
:	NULL
GAPDH	NULL
mRNA	NULL
ratio	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
times	NULL
over	NULL
the	NULL
24-hydroxylase/GAPDH	NULL
ratio	NULL
at	NULL
2	NULL
h	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

sis	NULL
of	NULL
polar	NULL
metabolites	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
this	NULL
correlation	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
polar	NULL
metabolites	NULL
were	NULL
24-hydroxylated	NULL
by	NULL
using	NULL
the	NULL
classical	NULL
periodate	NULL
cleavage	NULL
reaction	NULL
(	NULL
30	NULL
)	NULL
and	NULL
HPLC	NULL
elution	NULL
profiles	NULL
.	NULL

Polar	NULL
metabolites	NULL
synthesized	NULL
from	NULL
tritiated	NULL
250HD	NULL
;	NULL
by	NULL
untreated	NULL
cells	NULL
(	NULL
controls	NULL
)	NULL
or	NULL
by	NULL
monocytes	NULL
exposed	NULL
to	NULL
0.24	NULL
nmol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
for	NULL
18	NULL
h	NULL
were	NULL
subjected	NULL
to	NULL
8	NULL
%	NULL
NaIO	NULL
,	NULL
for	NULL
30	NULL
min	NULL
at	NULL
0-4	NULL
C	NULL
and	NULL
further	NULL
HPLC-purified	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

NaIO	NULL
,	NULL
cleaves	NULL
the	NULL
side	NULL
chain	NULL
of	NULL
cholecalciferols	NULL
between	NULL
adjacent	NULL
hydroxyl	NULL
groups	NULL
,	NULL
and	NULL
because	NULL
the	NULL
°H-250HD	NULL
;	NULL
used	NULL
as	NULL
substrate	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
labeled	NULL
at	NULL
€26	NULL
and	NULL
C27	NULL
,	NULL
both	NULL
C24	NULL
or	NULL
C26	NULL
hydroxylations	NULL
would	NULL
result	NULL
in	NULL
loss	NULL
of	NULL
radioactivity	NULL
after	NULL
periodate	NULL
treatment	NULL
.	NULL

25-26	NULL
di-hydroxylated	NULL
compounds	NULL
,	NULL
however	NULL
,	NULL
would	NULL
only	NULL
lose	NULL
half	NULL
of	NULL
the	NULL
tritium	NULL
.	NULL

Control	NULL
experiments	NULL
using	NULL
tritiated	NULL
250HD	NULL
;	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
showed	NULL
no	NULL
degradation	NULL
of	NULL
these	NULL
metabolites	NULL
by	NULL
NaIQO	NULL
,	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
NaIQO	NULL
,	NULL
treatment	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
produced	NULL
by	NULL
the	NULL
cells	NULL
,	NULL
confirming	NULL
its	NULL
specificity	NULL
of	NULL
action	NULL
for	NULL
vitamin	NULL
D	NULL
metabolites	NULL
containing	NULL
diols	NULL
.	NULL

In	NULL
three	NULL
independent	NULL
experiments	NULL
,	NULL
NaIO	NULL
,	NULL
treatment	NULL
resulted	NULL
in	NULL
a	NULL
total	NULL
loss	NULL
of	NULL
radioactivity	NULL
eluting	NULL
with	NULL
the	NULL
polar	NULL
metabolite	NULL
fraction	NULL
in	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-treated	NULL
monocytes	NULL
.	NULL

The	NULL
simultaneous	NULL
detection	NULL
by	NULL
HPLC	NULL
of	NULL
tritiated	NULL
metabolites	NULL
coeluting	NULL
with	NULL
1,24,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
-24-o0xo-vitamin	NULL
D	NULL
standards	NULL
in	NULL
monocytes	NULL
treated	NULL
with	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h	NULL
,	NULL
but	NULL
not	NULL
in	NULL
untreated	NULL
monocytes	NULL
,	NULL
suggested	NULL
that	NULL
induction	NULL
of	NULL
the	NULL
24-hydroxylation	NULL
pathway	NULL
in	NULL
normal	NULL
human	NULL
PBM	NULL
might	NULL
partially	NULL
account	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
polar	NULL
metabolite	NULL
synthesis	NULL
by	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

Furthermore	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
(	NULL
synthesis	NULL
of	NULL
DUSSO	NULL
ET	NULL
AL	NULL
.	NULL

JCE	NULL
&	NULL
M	NULL
»	NULL
1997	NULL
Vol	NULL
82	NULL
«	NULL
No	NULL
7	NULL
polar	NULL
metabolites	NULL
)	NULL
required	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
0.1	NULL
ug/ml	NULL
cycloheximide	NULL
for	NULL
4	NULL
h	NULL
did	NULL
not	NULL
affect	NULL
monocyte	NULL
viability	NULL
as	NULL
measured	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

However	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
5.7-fold	NULL
induction	NULL
of	NULL
the	NULL
synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
by	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
over	NULL
that	NULL
of	NULL
untreated	NULL
monocytes	NULL
was	NULL
totally	NULL
abolished	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
in	NULL
monocytes	NULL
exposed	NULL
to	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
the	NULL
sterol	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
cycloheximide	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
,	NULL
in	NULL
normal	NULL
monocytes	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
inhibition	NULL
of	NULL
its	NULL
synthesis	NULL
does	NULL
not	NULL
involve	NULL
rapid	NULL
mechanisms	NULL
and	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
kidney	NULL
and	NULL
intestine	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induces	NULL
its	NULL
degradation	NULL
through	NULL
enhancement	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
and	NULL
activity	NULL
.	NULL

Vitamin	NULL
D	NULL
metabolism	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
normal	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
To	NULL
assess	NULL
whether	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
control	NULL
its	NULL
own	NULL
synthesis	NULL
and	NULL
catabolism	NULL
is	NULL
lost	NULL
as	NULL
peripheral	NULL
monocytes	NULL
differentiate	NULL
to	NULL
tissue	NULL
macrophages	NULL
,	NULL
we	NULL
examined	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
production	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
in	NULL
PAM	NULL
obtained	NULL
from	NULL
healthy	NULL
adult	NULL
volunteers	NULL
by	NULL
bronchial	NULL
lavage	NULL
.	NULL

Normal	NULL
human	NULL
PAM	NULL
constitutively	NULL
express	NULL
1a-hydroxylase	NULL
activity	NULL
.	NULL

They	NULL
convert	NULL
250HD	NULL
;	NULL
(	NULL
S.A.	NULL
:	NULL
27.7	NULL
Ci/mmol	NULL
;	NULL
0.1	NULL
uCi	NULL
)	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
at	NULL
a	NULL
rate	NULL
of	NULL
5.2	NULL
+	NULL
1.4	NULL
fmol	NULL
/	NULL
ug	NULL
DNA	NULL
/h	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PBM	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
a	NULL
dose	NULL
response	NULL
to	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
control	NULL
of	NULL
its	NULL
synthesis	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
catabolism	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
in	NULL
normal	NULL
PAM	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
depicts	NULL
that	NULL
a	NULL
0.24	NULL
nmol/L	NULL
dose	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
was	NULL
ineffective	NULL
in	NULL
suppressing	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
production	NULL
.	NULL

A	NULL
4.8	NULL
nmol/L	NULL
concentration	NULL
of	NULL
the	NULL
sterol	NULL
was	NULL
required	NULL
to	NULL
reduce	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
synthesis	NULL
by	NULL
48.0	NULL
+	NULL
3.9	NULL
%	NULL
of	NULL
control	NULL
(	NULL
untreated	NULL
PAM	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
right	NULL
panel	NULL
shows	NULL
that	NULL
a	NULL
0.24	NULL
nmol/L	NULL
dose	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
.	NULL

Even	NULL
with	NULL
concentrations	NULL
of	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
that	NULL
is	NULL
20-100	NULL
times	NULL
higher	NULL
than	NULL
physiological	NULL
(	NULL
from	NULL
4.8-24.0	NULL
nmol/L	NULL
)	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
catabolic	NULL
pathways	NULL
was	NULL
only	NULL
1.5-fold	NULL
above	NULL
control	NULL
(	NULL
2.1	NULL
+	NULL
1.7	NULL
fmol	NULL
/	NULL
pg	NULL
DNA	NULL
/h	NULL
)	NULL
and	NULL
did	NULL
not	NULL
reach	NULL
statistical	NULL
significance	NULL
.	NULL

Table	NULL
1	NULL
shows	NULL
24-hydroxylase	NULL
:	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-treated	NULL
PAM	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
activity	NULL
of	NULL
enzymes	NULL
involved	NULL
in	NULL
catabolic	NULL
pathways	NULL
,	NULL
an	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
concentration	NULL
of	NULL
4.8	NULL
nmol/L	NULL
and	NULL
18-h	NULL
exposure	NULL
to	NULL
the	NULL
sterol	NULL
were	NULL
required	NULL
for	NULL
PAM	NULL
to	NULL
increase	NULL
24-hydroxylase	NULL
mRNA	NULL
to	NULL
detectable	NULL
levels	NULL
.	NULL

The	NULL
lower	NULL
sensitivity	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
of	NULL
PAM	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
a	NULL
decrease	NULL
in	NULL
VDR	NULL
,	NULL
as	NULL
we	NULL
found	NULL
no	NULL
difference	NULL
in	NULL
maximal	NULL
specific	NULL
binding	NULL
of	NULL
tritiated	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
the	NULL
VDR	NULL
between	NULL
PBM	NULL
and	NULL
PAM	NULL
(	NULL
PBM	NULL
:	NULL
0.65	NULL
+	NULL
0.1	NULL
fmol	NULL
/	NULL
ug	NULL
DNA	NULL
,	NULL
n	NULL
=	NULL
5	NULL
;	NULL
vs.	NULL
PAM	NULL
:	NULL
0.67	NULL
+	NULL
0.17	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

Vitamin	NULL
D	NULL
metabolism	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
We	NULL
examined	NULL
the	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
as	NULL
a	NULL
potential	NULL
model	NULL
of	NULL
tissue	NULL
macrophage	NULL
.	NULL

THP	NULL
-1	NULL
cells	NULL
differentiate	NULL
toward	NULL
a	NULL
macrophage-like	NULL
state	NULL
by	NULL
exposure	NULL
to	NULL
160	NULL
nmol/L	NULL
TPA	NULL
for	NULL
24	NULL
h	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Vitamin	NULL
D	NULL
metabolism	NULL
was	NULL
measured	NULL
in	NULL
phorbol	NULL
differentiated	NULL
THP-1	NULL
cells	NULL
(	NULL
dTHP-1	NULL
)	NULL
after	NULL
an	NULL
18	NULL
h	NULL
incubation	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
containing	NULL
Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
y-INTERFERON	NULL
INHIBITION	NULL
OF	NULL
VITAMIN	NULL
D	NULL
ACTION	NULL
2227	NULL
TABLE	NULL
2	NULL
.	NULL

Kinetic	NULL
parameters	NULL
of	NULL
the	NULL
la-hydroxylase	NULL
of	NULL
THP-1	NULL
cells	NULL
100	NULL
Synthesis	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
J	NULL
»	NULL
(	NULL
%	NULL
of	NULL
control	NULL
)	NULL
0.24	NULL
nM	NULL
-	NULL
4.8	NULL
nM	NULL
-	NULL
12	NULL
nM	NULL
--	NULL
24	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
3	NULL
WJ	NULL
Naas	NULL
!	NULL

300	NULL
Py	NULL
ed	NULL
&	NULL
|	NULL
~	NULL
&	NULL
lsd	NULL
Synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
(	NULL
%	NULL
over	NULL
control	NULL
)	NULL
0.24	NULL
nM	NULL
4.8	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
12	NULL
nM	NULL
24	NULL
nM	NULL
FiG	NULL
.	NULL

3	NULL
.	NULL

Dose	NULL
response	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
on	NULL
A	NULL
)	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
synthesis	NULL
and	NULL
B	NULL
)	NULL
synthesis	NULL
of	NULL
polar	NULL
metabolites	NULL
by	NULL
PAM	NULL
.	NULL

PAM	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
;	NULL
0.24	NULL
;	NULL
4.8	NULL
;	NULL
12	NULL
,	NULL
or	NULL
24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
4	NULL
h.	NULL
Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
duplicate	NULL
determinations	NULL
in	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
and	NULL
**	NULL
indicate	NULL
P	NULL
=	NULL
0.05	NULL
and	NULL
0.01	NULL
from	NULL
control	NULL
values	NULL
,	NULL
respectively	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

1,25	NULL
(	NULL
0OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
PBM	NULL
and	NULL
PAM	NULL
24-Hydroxylase	NULL
:	NULL
GAPDH	NULL
mRNA	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
(	NULL
nmol/L	NULL
)	NULL
PBM	NULL
PAM	NULL
0.24	NULL
0.147	NULL
+	NULL
0.05	NULL
(	NULL
7	NULL
)	NULL
Undetectable	NULL
4.8	NULL
0.800	NULL
+	NULL
0.115	NULL
(	NULL
2	NULL
)	NULL
0.028	NULL
+	NULL
0.07	NULL
(	NULL
8	NULL
)	NULL
PBM	NULL
and	NULL
PAM	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
RPMI	NULL
(	NULL
1	NULL
%	NULL
BSA	NULL
)	NULL
with	NULL
0	NULL
,	NULL
0.24	NULL
,	NULL
or	NULL
4.8	NULL
nM	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
for	NULL
18	NULL
h.	NULL
Total	NULL
RNA	NULL
was	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
24-hydroxylase	NULL
:	NULL
GAPDH	NULL
ratio	NULL
from	NULL
the	NULL
number	NULL
of	NULL
independent	NULL
experiments	NULL
shown	NULL
in	NULL
parentheses	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

1	NULL
%	NULL
fatty	NULL
acid	NULL
free	NULL
albumin	NULL
.	NULL

Table	NULL
2	NULL
demonstrates	NULL
that	NULL
dTHP-1	NULL
cells	NULL
convert	NULL
250HD	NULL
;	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
at	NULL
a	NULL
rate	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PAM	NULL
.	NULL

Also	NULL
,	NULL
similar	NULL
to	NULL
PAM	NULL
,	NULL
exposure	NULL
of	NULL
dTHP-1	NULL
cells	NULL
to	NULL
2000	NULL
IU/mL	NULL
.	NULL

of	NULL
y-IFEN	NULL
for	NULL
18	NULL
h	NULL
produced	NULL
a	NULL
30-fold	NULL
increase	NULL
in	NULL
the	NULL
Vmax	NULL
of	NULL
the	NULL
1	NULL
«	NULL
-hydroxylase	NULL
.	NULL

1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
production	NULL
by	NULL
Control	NULL
IFNy	NULL
En	NULL
6.2	NULL
+	NULL
1.6	NULL
(	NULL
4	NULL
)	NULL
8.9	NULL
+	NULL
5.6	NULL
(	NULL
2	NULL
)	NULL
Vimax	NULL
22.7	NULL
+	NULL
5.8	NULL
(	NULL
4	NULL
)	NULL
684.0	NULL
+	NULL
323.1	NULL
(	NULL
2	NULL
)	NULL
°	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
or	NULL
2000	NULL
IU/ml	NULL
IFNy	NULL
for	NULL
18	NULL
h.	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
,	NULL
;	NULL
,	NULL
production	NULL
was	NULL
measured	NULL
using	NULL
four	NULL
different	NULL
substrate	NULL
concentrations	NULL
(	NULL
from	NULL
5-300	NULL
nmol/L	NULL
)	NULL
.	NULL

K	NULL
,	NULL
,	NULL
,	NULL
(	NULL
nanomolar	NULL
concentrations	NULL
)	NULL
and	NULL
V	NULL
...	NULL
,	NULL
[	NULL
fentomoles	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
per	NULL
ug	NULL
DNA/h	NULL
)	NULL
values	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
double	NULL
reciprocal	NULL
plot	NULL
of	NULL
Lineweaver	NULL
and	NULL
Burk	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
from	NULL
the	NULL
number	NULL
of	NULL
independent	NULL
experiments	NULL
shown	NULL
in	NULL
parentheses	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

*	NULL
P	NULL
<	NULL
0.006	NULL
.	NULL

TABLE	NULL
3	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
cytochrome	NULL
P450	NULL
inhibitors	NULL
and	NULL
free	NULL
radical	NULL
scavengers	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
production	NULL
by	NULL
THP-1	NULL
cells	NULL
Control	NULL
IFNy	NULL
Basal	NULL
100	NULL
+	NULL
10.6	NULL
1310	NULL
+	NULL
160.7	NULL
Ketoconazole	NULL
20.1	NULL
+	NULL
9.2°	NULL
2.3	NULL
+	NULL
0.95°	NULL
EDTA	NULL
76.5	NULL
+	NULL
5.5	NULL
69.7	NULL
+	NULL
7.4	NULL
DPPD	NULL
78.4	NULL
+	NULL
14.8	NULL
79.1	NULL
+	NULL
8.9	NULL
dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
(	NULL
1	NULL
%	NULL
BSA	NULL
)	NULL
with	NULL
0	NULL
or	NULL
2000	NULL
IU/ml	NULL
IFNy	NULL
for	NULL
18	NULL
h.	NULL
Medium	NULL
was	NULL
removed	NULL
,	NULL
and	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
produced	NULL
in	NULL
1	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cytochrome	NULL
P450	NULL
inhibitor	NULL
ketoconazole	NULL
(	NULL
10	NULL
umol/L	NULL
)	NULL
or	NULL
the	NULL
free	NULL
radical	NULL
scavengers	NULL
EDTA	NULL
(	NULL
8	NULL
mM	NULL
)	NULL
or	NULL
N	NULL
,	NULL
N'-diphenylenethylendiamine	NULL
(	NULL
DPPD	NULL
;	NULL
10	NULL
umol/L	NULL
)	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
basal	NULL
production	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

*	NULL
P	NULL
<	NULL
0.01	NULL
vs.	NULL
control	NULL
values	NULL
.	NULL

resting	NULL
and	NULL
y-IFN	NULL
activated	NULL
THP-1	NULL
cells	NULL
was	NULL
totally	NULL
blocked	NULL
by	NULL
10	NULL
umol/L	NULL
ketoconazole	NULL
,	NULL
a	NULL
cytochrome	NULL
P450	NULL
inhibitor	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Basal	NULL
and	NULL
y-IFN	NULL
stimulated	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
production	NULL
by	NULL
THP-1	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
free	NULL
radical	NULL
scavengers	NULL
EDTA	NULL
(	NULL
3	NULL
mmol/L	NULL
)	NULL
,	NULL
or	NULL
by	NULL
N	NULL
,	NULL
N'-diphenylethylenediamine	NULL
(	NULL
10	NULL
/L	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
conversion	NULL
of	NULL
250HD	NULL
;	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
is	NULL
the	NULL
result	NULL
of	NULL
enzymatic	NULL
oxidation	NULL
of	NULL
250HD	NULL
;	NULL
involving	NULL
a	NULL
cytochrome	NULL
P45Q0-linked	NULL
hydroxylation	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
the	NULL
metabolite	NULL
synthesized	NULL
by	NULL
dTHP-1	NULL
cells	NULL
under	NULL
basal	NULL
or	NULL
yIFN	NULL
induced	NULL
states	NULL
is	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
by	NULL
the	NULL
following	NULL
criteria	NULL
:	NULL
1	NULL
)	NULL
coelution	NULL
with	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
standards	NULL
in	NULL
two	NULL
straight	NULL
phase	NULL
and	NULL
one	NULL
reverse	NULL
phase	NULL
HPLC	NULL
purifications	NULL
:	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
production	NULL
by	NULL
y-IFN	NULL
treated	NULL
THP-1	NULL
cells	NULL
was	NULL
high	NULL
enough	NULL
to	NULL
allow	NULL
the	NULL
detection	NULL
at	NULL
a	NULL
wavelength	NULL
of	NULL
265	NULL
nm	NULL
of	NULL
a	NULL
peak	NULL
with	NULL
the	NULL
retention	NULL
time	NULL
of	NULL
authentic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
in	NULL
the	NULL
chromatograms	NULL
from	NULL
the	NULL
three	NULL
HPLC	NULL
systems	NULL
;	NULL
2	NULL
)	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
endogenously	NULL
produced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
activity	NULL
:	NULL
60	NULL
and	NULL
287	NULL
fmoles	NULL
of	NULL
24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
were	NULL
generated	NULL
in	NULL
4	NULL
and	NULL
6	NULL
h	NULL
,	NULL
respectively	NULL
,	NULL
by	NULL
resting	NULL
THP-1	NULL
cells	NULL
incubated	NULL
with	NULL
12	NULL
nmol/L	NULL
°H-250HD	NULL
;	NULL
alone	NULL
.	NULL

In	NULL
y-IEN	NULL
treated	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
no	NULL
detectable	NULL
24,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
despite	NULL
endogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
levels	NULL
5.6-fold	NULL
above	NULL
those	NULL
of	NULL
resting	NULL
THP-1	NULL
cells	NULL
;	NULL
and	NULL
3	NULL
)	NULL
the	NULL
affinity	NULL
of	NULL
the	NULL
HPLC	NULL
purified	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
for	NULL
the	NULL
VDR	NULL
:	NULL
comparison	NULL
of	NULL
the	NULL
displacement	NULL
of	NULL
°H-1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
from	NULL
the	NULL
calf	NULL
thymus	NULL
receptor	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
standards	NULL
and	NULL
different	NULL
dilutions	NULL
of	NULL
the	NULL
HPLC-purified	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesized	NULL
in	NULL
4	NULL
h	NULL
rendered	NULL
actual	NULL
concentrations	NULL
of	NULL
putative	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
of	NULL
3.7	NULL
and	NULL
3.1	NULL
ng	NULL
in	NULL
control	NULL
cells	NULL
and	NULL
18.3	NULL
ng	NULL
in	NULL
y-IFN	NULL
treated	NULL
THP-1	NULL
cells	NULL
.	NULL

Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
2228	NULL
These	NULL
values	NULL
did	NULL
not	NULL
differ	NULL
from	NULL
the	NULL
expected	NULL
concentrations	NULL
of	NULL
3.9	NULL
,	NULL
2.2	NULL
,	NULL
and	NULL
15.3	NULL
ng	NULL
estimated	NULL
from	NULL
the	NULL
rate	NULL
of	NULL
conversion	NULL
of	NULL
°H-250HD	NULL
;	NULL
to	NULL
°H-1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
using	NULL
one	NULL
single	NULL
HPLC	NULL
purification	NULL
after	NULL
correction	NULL
for	NULL
recoveries	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
dTHP-1	NULL
cells	NULL
respond	NULL
to	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
like	NULL
PBM	NULL
or	NULL
PAM	NULL
.	NULL

Similar	NULL
to	NULL
PAM	NULL
,	NULL
THP-1	NULL
cells	NULL
did	NULL
not	NULL
respond	NULL
to	NULL
0.24	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
3	NULL
even	NULL
after	NULL
an	NULL
18-h	NULL
exposure	NULL
.	NULL

They	NULL
required	NULL
4.8	NULL
nmol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
67.3	NULL
%	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
and	NULL
to	NULL
induce	NULL
vitamin	NULL
D	NULL
catabolism	NULL
2.3-fold	NULL
over	NULL
controls	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
in	NULL
4	NULL
h.	NULL
Figure	NULL
4	NULL
shows	NULL
that	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
3	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
also	NULL
required	NULL
a	NULL
concentration	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
10	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
effective	NULL
in	NULL
PBM	NULL
.	NULL

The	NULL
lower	NULL
sensitivity	NULL
of	NULL
THP-1	NULL
cells	NULL
is	NULL
unrelated	NULL
to	NULL
a	NULL
reduced	NULL
VDR	NULL
content	NULL
as	NULL
the	NULL
maximal	NULL
specific	NULL
binding	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
the	NULL
VDR	NULL
in	NULL
THP-1	NULL
cells	NULL
was	NULL
0.60	NULL
+	NULL
0.05	NULL
fmol	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
/ug	NULL
DNA	NULL
;	NULL
n	NULL
=	NULL
4	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PAM	NULL
.	NULL

These	NULL
studies	NULL
rendered	NULL
THP-1	NULL
cells	NULL
the	NULL
first	NULL
available	NULL
model	NULL
of	NULL
human	NULL
macrophages	NULL
to	NULL
study	NULL
cytokine	NULL
regulation	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
action	NULL
.	NULL

Effects	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
action	NULL
To	NULL
assess	NULL
the	NULL
effects	NULL
of	NULL
macrophage-activation	NULL
on	NULL
the	NULL
response	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
dTHP-1	NULL
cells	NULL
were	NULL
coincubated	NULL
with	NULL
9.6	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
a	NULL
dose	NULL
effective	NULL
to	NULL
inhibit	NULL
synthesis	NULL
and	NULL
induce	NULL
catabolism	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
controls	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2000	NULL
IU/mL	NULL
.	NULL

of	NULL
y-IFN	NULL
,	NULL
the	NULL
cytokine	NULL
responsible	NULL
for	NULL
endogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
overproduction	NULL
in	NULL
sarcoidosis	NULL
and	NULL
tuberculosis	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
at	NULL
37	NULL
C	NULL
for	NULL
18	NULL
h.	NULL
y-IFN	NULL
blocked	NULL
the	NULL
ability	NULL
of	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
to	NULL
suppress	NULL
1a	NULL
«	NULL
-hydroxy-lase	NULL
activity	NULL
and	NULL
caused	NULL
a	NULL
42.2	NULL
%	NULL
reduction	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
-mediated	NULL
induction	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
degradation	NULL
[	NULL
Control	NULL
:	NULL
13.2	NULL
+	NULL
2.3	NULL
fmol	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
/ug	NULL
DNA/h	NULL
,	NULL
n	NULL
=	NULL
2	NULL
;	NULL
y-IEN	NULL
:	NULL
7.5	NULL
+	NULL
0.3	NULL
,	NULL
n	NULL
=	NULL
2	NULL
;	NULL
P	NULL
<	NULL
0.05	NULL
]	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
whether	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
y-IFN	NULL
was	NULL
limited	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
modulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
1	NULL
«	NULL
-and	NULL
24-hydroxylases	NULL
,	NULL
or	NULL
if	NULL
it	NULL
extended	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
.	NULL

THP-1	NULL
cells	NULL
2.00	NULL
<	NULL
F4	NULL
CC	NULL
E	NULL
1.50	NULL
I	NULL
a	NULL
A	NULL
.	NULL

<	NULL
4	NULL
0	NULL
s	NULL
|	NULL
d	NULL
1.00	NULL
E	NULL
>	NULL
%	NULL
0	NULL
i	NULL
C	NULL
2	NULL
oso	NULL
<	NULL
bl	NULL
0.00	NULL
o	NULL
0.24	NULL
2.4	NULL
4.8	NULL
9.6	NULL
24	NULL
1,25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
,	NULL
FiG	NULL
.	NULL

4	NULL
.	NULL

Dose	NULL
response	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
dTHP-1	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
THP-1	NULL
cells	NULL
exposed	NULL
to	NULL
0	NULL
,	NULL
0.24	NULL
,	NULL
2.4	NULL
,	NULL
4.8	NULL
,	NULL
9.6	NULL
or	NULL
24	NULL
,	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
for	NULL
18	NULL
h	NULL
was	NULL
assayed	NULL
for	NULL
mRNA	NULL
levels	NULL
of	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
the	NULL
24-hydroxylase/GAPDH	NULL
ratio	NULL
from	NULL
duplicate	NULL
determinations	NULL
.	NULL

DUSSO	NULL
ET	NULL
AL	NULL
.	NULL

JCE	NULL
&	NULL
M	NULL
»	NULL
1997	NULL
Vol	NULL
82	NULL
«	NULL
No	NULL
7	NULL
were	NULL
exposed	NULL
to	NULL
0	NULL
(	NULL
control	NULL
)	NULL
or	NULL
9.6	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
a	NULL
dose	NULL
that	NULL
effectively	NULL
induces	NULL
24-hydroxylase	NULL
mRNA	NULL
,	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
y-IFN	NULL
(	NULL
from	NULL
5-2000	NULL
IU/mL	NULL
.	NULL
)	NULL

for	NULL
18	NULL
h.	NULL
Figure	NULL
5	NULL
shows	NULL
that	NULL
y-IFN	NULL
blocks	NULL
the	NULL
ability	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
mRNA	NULL
in	NULL
THP-1	NULL
cells	NULL
in	NULL
a	NULL
dose	NULL
dependent	NULL
manner	NULL
.	NULL

Five	NULL
IU/mL	NULL
y-IFN	NULL
decreased	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
by	NULL
50.1	NULL
%	NULL
with	NULL
maximal	NULL
inhibition	NULL
(	NULL
86	NULL
%	NULL
)	NULL
achieved	NULL
with	NULL
concentrations	NULL
of	NULL
the	NULL
cytokine	NULL
higher	NULL
than	NULL
20	NULL
IU/mL	NULL
.	NULL

We	NULL
next	NULL
measured	NULL
VDR	NULL
content	NULL
of	NULL
y-IFN	NULL
-treated	NULL
dTHP-1	NULL
.	NULL

In	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
maximal	NULL
specific	NULL
binding	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
the	NULL
VDR	NULL
was	NULL
similar	NULL
in	NULL
controls	NULL
(	NULL
0.67	NULL
+	NULL
0.04	NULL
fmol	NULL
1	NULL
,	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
/	NULL
ug	NULL
DNA	NULL
)	NULL
and	NULL
in	NULL
THP-1	NULL
cells	NULL
treated	NULL
with	NULL
25	NULL
IU/mL	NULL
of	NULL
yIFN	NULL
(	NULL
0.59	NULL
+	NULL
0.02	NULL
fmol	NULL
1	NULL
,	NULL
25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
/	NULL
ug	NULL
DNA	NULL
)	NULL
,	NULL
a	NULL
dose	NULL
that	NULL
elicited	NULL
maximal	NULL
inhibition	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
increase	NULL
in	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
.	NULL

Higher	NULL
concentrations	NULL
of	NULL
the	NULL
cytokine	NULL
(	NULL
100	NULL
and	NULL
2000	NULL
IU/mL	NULL
)	NULL
reduced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
binding	NULL
to	NULL
the	NULL
VDR	NULL
to	NULL
69.0	NULL
%	NULL
+	NULL
7.1	NULL
and	NULL
69.2	NULL
%	NULL
+	NULL
9.6	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
of	NULL
controls	NULL
,	NULL
respectively	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
decrease	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR	NULL
binding	NULL
with	NULL
increasing	NULL
y-IFN	NULL
concentrations	NULL
can	NULL
not	NULL
account	NULL
for	NULL
the	NULL
dramatic	NULL
loss	NULL
of	NULL
responsiveness	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
the	NULL
observed	NULL
inhibitory	NULL
effects	NULL
of	NULL
y-INF	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
actions	NULL
were	NULL
physiologically	NULL
relevant	NULL
or	NULL
an	NULL
artifact	NULL
of	NULL
the	NULL
treatment	NULL
with	NULL
phorbol-ester	NULL
to	NULL
induce	NULL
THP-1	NULL
cells	NULL
to	NULL
differentiate	NULL
to	NULL
a	NULL
macrophage-like	NULL
phenotype	NULL
,	NULL
we	NULL
used	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
from	NULL
normal	NULL
volunteers	NULL
to	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
2000	NULL
U/mL	NULL
y-INF	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
suppression	NULL
of	NULL
la-hydroxylase	NULL
activity	NULL
,	NULL
and	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
cytokine	NULL
on	NULL
dTHP-1	NULL
cells	NULL
,	NULL
2000	NULL
IU	NULL
/ml	NULL
y-IFN	NULL
blocked	NULL
the	NULL
ability	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
(	NULL
0.24	NULL
nmol/L	NULL
)	NULL
to	NULL
inhibit	NULL
1a-hydroxylase	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Fig	NULL
.	NULL

6	NULL
shows	NULL
the	NULL
effects	NULL
of	NULL
18	NULL
h	NULL
exposure	NULL
to	NULL
a	NULL
dose	NULL
of	NULL
2000	NULL
IU/mL	NULL
of	NULL
y-IFN	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
by	NULL
0.24	NULL
nmol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
in	NULL
PBM	NULL
from	NULL
4	NULL
normal	NULL
adults	NULL
.	NULL

24-hydroxylase	NULL
mRNA	NULL
levels	NULL
were	NULL
undetectable	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
untreated	NULL
monocytes	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
y-IFN	NULL
reduced	NULL
by	NULL
79.4	NULL
%	NULL
+	NULL
9.5	NULL
0.50	NULL
0.40	NULL
0.30	NULL
r	NULL
0.20	NULL
|	NULL
24-hydroxylase/GAPDH	NULL
mRNA	NULL
0.00	NULL
IFN	NULL
(	NULL
U/ml	NULL
)	NULL
0	NULL
0	NULL
5	NULL
25	NULL
50	NULL
100	NULL
1000	NULL
2000	NULL
1,25D	NULL
(	NULL
nM	NULL
)	NULL
0	NULL
>	NULL
9.6	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Dose	NULL
response	NULL
for	NULL
y-IFN	NULL
inhibition	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
dTHP-1	NULL
cells	NULL
.	NULL

dTHP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
0	NULL
or	NULL
9.6	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
;	NULL
D	NULL
,	NULL
(	NULL
1	NULL
,	NULL
25	NULL
(	NULL
0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
)	NULL
and	NULL
increasing	NULL
concentrations	NULL
of	NULL
y-IFN	NULL
(	NULL
IFN	NULL
)	NULL
from	NULL
0-2000	NULL
IU/ml	NULL
for	NULL
18	NULL
h.	NULL
Total	NULL
RNA	NULL
was	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
.	NULL

Results	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
the	NULL
24-hydroxylase/GAPDH	NULL
mRNA	NULL
ratio	NULL
from	NULL
duplicate	NULL
determinations	NULL
.	NULL

Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
y-INTERFERON	NULL
INHIBITION	NULL
OF	NULL
VITAMIN	NULL
D	NULL
ACTION	NULL
24-hydroxylase	NULL
64	NULL
GAPDH	NULL
Hip	NULL
«	NULL
~	NULL
jib	NULL
W	NULL
UHR	NULL
ae	NULL
am	NULL
imns	NULL
CTRL	NULL
l	NULL
1,25D	NULL
i	NULL
1,25D	NULL
+	NULL
IFN	NULL
0.16	NULL
wl	NULL
___	NULL
ZA	NULL
j	NULL
604	NULL
/	NULL
/\\	NULL
0	NULL
U	NULL
t	NULL
CTRL	NULL
1,25D	NULL
1,25+INF	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25	NULL
(	NULL
O0H	NULL
)	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
PBM	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
untreated	NULL
PBM	NULL
(	NULL
Ctrl	NULL
)	NULL
or	NULL
from	NULL
cells	NULL
exposed	NULL
to	NULL
0.24	NULL
nmol/L	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
alone	NULL
(	NULL
1	NULL
,	NULL
25D	NULL
)	NULL
or	NULL
with	NULL
2000	NULL
IU/mL	NULL
y-IFN	NULL
(	NULL
1	NULL
,	NULL
25D	NULL
+	NULL
y-IFN	NULL
)	NULL
was	NULL
assayed	NULL
for	NULL
mRNA	NULL
levels	NULL
of	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
.	NULL

Upper	NULL
panel	NULL
:	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
protected	NULL
fragments	NULL
in	NULL
monocytes	NULL
from	NULL
the	NULL
same	NULL
individual	NULL
.	NULL

Lower	NULL
panel	NULL
:	NULL
Densitometric	NULL
analysis	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
:	NULL
GAPDH	NULL
ratio	NULL
in	NULL
PBM	NULL
from	NULL
4	NULL
normal	NULL
volunteers	NULL
.	NULL

Values	NULL
for	NULL
each	NULL
individual	NULL
studied	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
triplicate	NULL
determinations	NULL
.	NULL

24-hydroxylase/GAPDH	NULL
mRNA	NULL
the	NULL
24-hydroxylaseGAPDH	NULL
mRNA	NULL
ratio	NULL
induced	NULL
by	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
.	NULL

A	NULL
potential	NULL
post-transcriptional	NULL
mechanism	NULL
for	NULL
y-IFN	NULL
to	NULL
reduce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
would	NULL
be	NULL
to	NULL
decrease	NULL
the	NULL
stability	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
measured	NULL
the	NULL
half	NULL
life	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
in	NULL
untreated	NULL
and	NULL
y-IFN	NULL
treated	NULL
THP-1	NULL
cells	NULL
.	NULL

Fig	NULL
.	NULL

7	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
depicts	NULL
the	NULL
single	NULL
exponential	NULL
decays	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
with	NULL
time	NULL
after	NULL
blocking	NULL
further	NULL
transcription	NULL
with	NULL
the	NULL
RNAse	NULL
polymerase	NULL
II	NULL
inhibitor	NULL
actinomycin	NULL
D	NULL
in	NULL
y-IFEN	NULL
treated	NULL
and	NULL
untreated	NULL
THP-1	NULL
cells	NULL
.	NULL

In	NULL
two	NULL
independent	NULL
experiments	NULL
,	NULL
the	NULL
estimated	NULL
half	NULL
life	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
was	NULL
4.5	NULL
+	NULL
0.15	NULL
h	NULL
in	NULL
control	NULL
cells	NULL
and	NULL
4.9	NULL
+	NULL
1.3	NULL
h	NULL
in	NULL
y-IFN	NULL
treated	NULL
dTHP-1	NULL
cells	NULL
.	NULL

Clearly	NULL
,	NULL
y-IFN	NULL
does	NULL
not	NULL
reduce	NULL
24-hydroxylase	NULL
mRNA	NULL
stability	NULL
,	NULL
as	NULL
better	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
when	NULL
the	NULL
24-hydroxylase/	NULL
GAPDH	NULL
mRNA	NULL
ratio	NULL
is	NULL
plotted	NULL
as	NULL
percent	NULL
of	NULL
time	NULL
0	NULL
.	NULL

This	NULL
suggests	NULL
an	NULL
antagonistic	NULL
effect	NULL
of	NULL
the	NULL
cytokine	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
.	NULL

Discussion	NULL
We	NULL
have	NULL
identified	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
the	NULL
resistance	NULL
of	NULL
disease-activated	NULL
macrophages	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
which	NULL
causes	NULL
supranormal	NULL
serum	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
levels	NULL
and	NULL
2229	NULL
0.60	NULL
120	NULL
«	NULL
.	NULL

pa	NULL
1	NULL
&	NULL
-	NULL
0.50	NULL
}	NULL
100	NULL
§	NULL
6	NULL
I	NULL
_	NULL
0	NULL
&	NULL
-	NULL
0.40	NULL
}	NULL
s	NULL
so	NULL
|	NULL
§	NULL
<	NULL
[	NULL
~	NULL
5	NULL
0	NULL
©	NULL
a	NULL
0	NULL
s	NULL
$	NULL
-	NULL
_	NULL
9	NULL
g	NULL
-	NULL
60	NULL
8	NULL
|	NULL
8	NULL
6	NULL
6	NULL
3	NULL
>	NULL
5	NULL
E	NULL
T	NULL
%	NULL
L	NULL
§	NULL
0.20	NULL
o	NULL
x	NULL
40	NULL
§	NULL
ke	NULL
>	NULL
o	NULL
To	NULL
odo	NULL
}	NULL
o	NULL
20	NULL
<	NULL
SJ	NULL
0.00	NULL
-	NULL
0	NULL
0	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
0	NULL
1	NULL
2	NULL
s	NULL
4	NULL
50	NULL
6	NULL
7	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Time	NULL
(	NULL
h	NULL
)	NULL
Fic	NULL
.	NULL

7	NULL
.	NULL

Effect	NULL
of	NULL
y-IFN	NULL
on	NULL
the	NULL
half	NULL
life	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
.	NULL

dTHP-1	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
9.6	NULL
nmol/L	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
and	NULL
0	NULL
or	NULL
20	NULL
U/mL	NULL
y-IFN	NULL
for	NULL
18	NULL
h.	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
RNA	NULL
polymerase	NULL
inhibitor	NULL
actinomycin	NULL
D	NULL
were	NULL
then	NULL
added	NULL
to	NULL
block	NULL
further	NULL
transcription	NULL
.	NULL

Total	NULL
mRNA	NULL
was	NULL
collected	NULL
at	NULL
time	NULL
0	NULL
and	NULL
at	NULL
1,2,4	NULL
,	NULL
and	NULL
6	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D	NULL
and	NULL
assayed	NULL
for	NULL
24-hydroxylase	NULL
and	NULL
GAPDH	NULL
mRNA	NULL
levels	NULL
.	NULL

Panel	NULL
A	NULL
depicts	NULL
the	NULL
decay	NULL
in	NULL
24-hydroxylase/GAPDH	NULL
ratio	NULL
in	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
and	NULL
y-IFN	NULL
treated	NULL
(	NULL
]	NULL
)	NULL
dTHP-1	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
triplicate	NULL
determinations	NULL
from	NULL
one	NULL
representative	NULL
experiment	NULL
.	NULL

Panel	NULL
B	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
triplicate	NULL
determinations	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
data	NULL
represents	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
24-hydroxylase/GAPDH	NULL
mRNA	NULL
levels	NULL
expressed	NULL
as	NULL
percent	NULL
from	NULL
the	NULL
ratio	NULL
at	NULL
time	NULL
0	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D.	NULL
hypercalcemia	NULL
in	NULL
various	NULL
granulomatoses	NULL
.	NULL

The	NULL
demonstration	NULL
that	NULL
the	NULL
VDR	NULL
content	NULL
does	NULL
not	NULL
change	NULL
with	NULL
macrophage	NULL
activation	NULL
(	NULL
22	NULL
)	NULL
suggests	NULL
that	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
inhibition	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte-macrophage	NULL
lineage	NULL
may	NULL
involve	NULL
rapid	NULL
,	NULL
nongenomic	NULL
mechanisms	NULL
similar	NULL
to	NULL
the	NULL
1a-hydroxylase	NULL
of	NULL
kidney	NULL
cell	NULL
cultures	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Time	NULL
course	NULL
experiments	NULL
in	NULL
normal	NULL
PBM	NULL
ruled	NULL
out	NULL
the	NULL
involvement	NULL
of	NULL
rapid	NULL
,	NULL
nongenomic	NULL
actions	NULL
in	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
control	NULL
of	NULL
monocytic	NULL
1a-hydroxylase	NULL
.	NULL

1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
suppression	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
required	NULL
at	NULL
least	NULL
a	NULL
2-h	NULL
exposure	NULL
to	NULL
physiological	NULL
concentrations	NULL
of	NULL
the	NULL
sterol	NULL
.	NULL

Even	NULL
with	NULL
concentrations	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
ten	NULL
times	NULL
above	NULL
the	NULL
normal	NULL
range	NULL
,	NULL
no	NULL
feedback	NULL
inhibition	NULL
of	NULL
monocyte	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
was	NULL
detected	NULL
within	NULL
the	NULL
first	NULL
hour	NULL
.	NULL

Although	NULL
conclusive	NULL
evidence	NULL
of	NULL
a	NULL
genomic	NULL
control	NULL
by	NULL
the	NULL
sterol	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
awaits	NULL
the	NULL
cloning	NULL
of	NULL
the	NULL
1a	NULL
«	NULL
-hydroxylase	NULL
,	NULL
the	NULL
recent	NULL
demonstration	NULL
of	NULL
enhanced	NULL
1	NULL
«	NULL
-hydroxylase	NULL
activity	NULL
and	NULL
high	NULL
serum	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
levels	NULL
in	NULL
the	NULL
VDR	NULL
knockout	NULL
mouse	NULL
(	NULL
35	NULL
)	NULL
supports	NULL
our	NULL
finding	NULL
that	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
suppression	NULL
of	NULL
its	NULL
own	NULL
synthesis	NULL
may	NULL
be	NULL
a	NULL
VDR	NULL
mediated	NULL
process	NULL
.	NULL

The	NULL
striking	NULL
difference	NULL
in	NULL
the	NULL
sensitivity	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
inhibition	NULL
of	NULL
la-hydroxylase	NULL
activity	NULL
between	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
the	NULL
precursors	NULL
of	NULL
tissue	NULL
macrophages	NULL
,	NULL
and	NULL
activated	NULL
macrophages	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
cellular	NULL
signaling	NULL
pathways	NULL
required	NULL
by	NULL
the	NULL
sterol	NULL
are	NULL
lost	NULL
either	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
peripheral	NULL
monocytes	NULL
to	NULL
tissue	NULL
macrophages	NULL
or	NULL
as	NULL
a	NULL
result	NULL
of	NULL
macrophage	NULL
activation	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
contribution	NULL
of	NULL
monocyte	NULL
differentiation	NULL
in	NULL
macrophage-resistance	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
we	NULL
examined	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
control	NULL
of	NULL
its	NULL
synthesis	NULL
in	NULL
PAM	NULL
obtained	NULL
by	NULL
bronchial	NULL
lavage	NULL
from	NULL
healthy	NULL
adult	NULL
volunteers	NULL
.	NULL

PAM	NULL
constitutively	NULL
express	NULL
l-hydroxylase	NULL
activity	NULL
,	NULL
and	NULL
the	NULL
rate	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
production	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PBM	NULL
.	NULL

However	NULL
,	NULL
a	NULL
concentration	NULL
of	NULL
Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
22830	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
20	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
effective	NULL
in	NULL
PBM	NULL
was	NULL
required	NULL
to	NULL
reduce	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
synthesis	NULL
by	NULL
50	NULL
%	NULL
.	NULL

Thus	NULL
,	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
is	NULL
capable	NULL
of	NULL
suppressing	NULL
its	NULL
synthesis	NULL
in	NULL
normal	NULL
PAM	NULL
with	NULL
a	NULL
lower	NULL
potency	NULL
.	NULL

This	NULL
contrasts	NULL
markedly	NULL
with	NULL
the	NULL
lack	NULL
of	NULL
feedback	NULL
inhibition	NULL
by	NULL
the	NULL
sterol	NULL
of	NULL
macrophage	NULL
1	NULL
«	NULL
-hydroxylase	NULL
of	NULL
human	NULL
PAM	NULL
activated	NULL
in	NULL
vivo	NULL
by	NULL
underlying	NULL
diseases	NULL
such	NULL
as	NULL
sarcoidosis	NULL
(	NULL
7	NULL
)	NULL
,	NULL
tuberculosis	NULL
(	NULL
8	NULL
)	NULL
,	NULL
various	NULL
granulomatoses	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
9	NULL
)	NULL
,	NULL
or	NULL
in	NULL
vitro	NULL
after	NULL
exposure	NULL
of	NULL
normal	NULL
PAM	NULL
to	NULL
y-IFN	NULL
(	NULL
10	NULL
)	NULL
or	NULL
TNFa	NULL
(	NULL
21	NULL
)	NULL
.	NULL

This	NULL
led	NULL
us	NULL
to	NULL
hypothesize	NULL
cytokine-induced	NULL
resistance	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
control	NULL
of	NULL
its	NULL
synthesis	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hy-pothesis	NULL
,	NULL
we	NULL
overcame	NULL
difficulties	NULL
in	NULL
obtaining	NULL
human	NULL
macrophages	NULL
by	NULL
examining	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
as	NULL
a	NULL
potential	NULL
model	NULL
of	NULL
tissue	NULL
macrophage	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
chosen	NULL
because	NULL
of	NULL
their	NULL
ability	NULL
to	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
toward	NULL
a	NULL
macrophage-like	NULL
state	NULL
by	NULL
exposure	NULL
to	NULL
phorbol	NULL
esters	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Phorbol-differentiated	NULL
THP-1	NULL
cells	NULL
mimic	NULL
more	NULL
closely	NULL
monocyte	NULL
derived	NULL
macrophages	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
oncogenes	NULL
and	NULL
membrane	NULL
proteins	NULL
than	NULL
their	NULL
more	NULL
widely	NULL
used	NULL
counterparts	NULL
,	NULL
HL-60	NULL
or	NULL
U937	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
phorbol-differentiated	NULL
THP-1	NULL
cells	NULL
mimic	NULL
normal	NULL
PAM	NULL
in	NULL
the	NULL
constitutive	NULL
expression	NULL
of	NULL
1	NULL
«	NULL
-hydroxylase	NULL
activity	NULL
and	NULL
in	NULL
the	NULL
30	NULL
fold-increase	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
,	NULL
production	NULL
in	NULL
response	NULL
to	NULL
y-IFN	NULL
.	NULL

The	NULL
metabolite	NULL
synthesized	NULL
by	NULL
resting	NULL
and	NULL
y-IFN	NULL
activated	NULL
THP-1	NULL
cells	NULL
is	NULL
authentic	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
based	NULL
on	NULL
its	NULL
chromatographic	NULL
properties	NULL
,	NULL
the	NULL
affinity	NULL
for	NULL
the	NULL
calf	NULL
thymus	NULL
VDR	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
24-hydroxylase	NULL
activity	NULL
.	NULL

Basal	NULL
and	NULL
y-IFN	NULL
induced	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
in	NULL
THP-1	NULL
cells	NULL
were	NULL
totally	NULL
blocked	NULL
by	NULL
the	NULL
cytochrome	NULL
P450	NULL
inhibitor	NULL
ketoconazole	NULL
,	NULL
and	NULL
unaffected	NULL
by	NULL
the	NULL
free	NULL
radical	NULL
scavengers	NULL
ethylenediamine	NULL
tetracetic	NULL
acid	NULL
or	NULL
diparaphenylenediamine	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
renal	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
,	NULL
PBM	NULL
(	NULL
12	NULL
)	NULL
,	NULL
and	NULL
sarcoid	NULL
PAM	NULL
1la-hydroxylases	NULL
(	NULL
11	NULL
)	NULL
,	NULL
the	NULL
conversion	NULL
of	NULL
250HD	NULL
;	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
THP-1	NULL
cells	NULL
is	NULL
an	NULL
enzymatic	NULL
cytochrome	NULL
P450-linked	NULL
hydroxylation	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
THP-1	NULL
cells	NULL
to	NULL
suppress	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
synthesis	NULL
in	NULL
response	NULL
to	NULL
exogenous	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
is	NULL
also	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
PAM	NULL
and	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
PBM	NULL
.	NULL

Thus	NULL
,	NULL
THP-1	NULL
cells	NULL
provide	NULL
a	NULL
proper	NULL
model	NULL
of	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
.	NULL

The	NULL
demonstration	NULL
that	NULL
a	NULL
concentration	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
effective	NULL
to	NULL
suppress	NULL
1	NULL
«	NULL
-hydroxylase	NULL
activity	NULL
in	NULL
resting	NULL
THP-1	NULL
cells	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
y-IFN	NULL
supports	NULL
the	NULL
existence	NULL
of	NULL
cytokine-induced	NULL
resistance	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
the	NULL
feedback	NULL
inhibition	NULL
of	NULL
macrophage	NULL
1	NULL
«	NULL
-hydroxylase	NULL
.	NULL

Part	NULL
of	NULL
the	NULL
decrease	NULL
in	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
by	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
may	NULL
result	NULL
from	NULL
the	NULL
well	NULL
known	NULL
genomic	NULL
action	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
its	NULL
own	NULL
degradation	NULL
(	NULL
15-19	NULL
)	NULL
.	NULL

In	NULL
nearly	NULL
all	NULL
target	NULL
tissues	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induces	NULL
24-hydroxylase	NULL
,	NULL
the	NULL
key	NULL
enzyme	NULL
in	NULL
mammalian	NULL
vitamin	NULL
D	NULL
catabolism	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

Previous	NULL
reports	NULL
from	NULL
our	NULL
laboratory	NULL
in	NULL
normal	NULL
monocytes	NULL
have	NULL
shown	NULL
that	NULL
physiological	NULL
concentrations	NULL
of	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induce	NULL
vitamin	NULL
D	NULL
catabolism	NULL
(	NULL
12	NULL
,	NULL
23	NULL
)	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
degradation	NULL
(	NULL
24	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
C24-hydroxylation	NULL
pathway	NULL
in	NULL
both	NULL
processes	NULL
has	NULL
not	NULL
been	NULL
evaluated	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
demonstrate	NULL
that	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
vitamin	NULL
D	NULL
catabolism	NULL
also	NULL
requires	NULL
a	NULL
2-h	NULL
exposure	NULL
to	NULL
the	NULL
sterol	NULL
and	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
,	NULL
suggesting	NULL
the	NULL
involvement	NULL
of	NULL
a	NULL
genomic	NULL
mechanism	NULL
.	NULL

The	NULL
time	NULL
course	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
paralleled	NULL
the	NULL
in	NULL
DUSSO	NULL
ET	NULL
AL	NULL
.	NULL

JCE	NULL
&	NULL
M	NULL
»	NULL
1997	NULL
Vol	NULL
82	NULL
«	NULL
No	NULL
7	NULL
crease	NULL
in	NULL
synthesis	NULL
of	NULL
24-hydroxylated	NULL
polar	NULL
metabolites	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
kidney	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
and	NULL
intestine	NULL
(	NULL
17	NULL
)	NULL
,	NULL
in	NULL
normal	NULL
PBM	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induces	NULL
250HD	NULL
;	NULL
,	NULL
catabolism	NULL
and	NULL
its	NULL
own	NULL
degradation	NULL
through	NULL
enhancement	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cytokine-activated	NULL
macrophages	NULL
exhibit	NULL
no	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
activity	NULL
by	NULL
either	NULL
the	NULL
excessive	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
levels	NULL
endogenously	NULL
generated	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
or	NULL
in	NULL
response	NULL
to	NULL
concentrations	NULL
of	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
400	NULL
times	NULL
above	NULL
the	NULL
normal	NULL
range	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Perhaps	NULL
,	NULL
cytokines	NULL
also	NULL
impair	NULL
the	NULL
genomic	NULL
actions	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
and	NULL
we	NULL
utilized	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-induction	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
to	NULL
further	NULL
characterize	NULL
the	NULL
mechanisms	NULL
involved	NULL
.	NULL

Studies	NULL
in	NULL
PAM	NULL
and	NULL
THP-1	NULL
cells	NULL
demonstrated	NULL
that	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
response	NULL
to	NULL
the	NULL
sterol	NULL
in	NULL
the	NULL
control	NULL
of	NULL
its	NULL
synthesis	NULL
,	NULL
a	NULL
concentration	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
20	NULL
times	NULL
higher	NULL
than	NULL
that	NULL
effective	NULL
in	NULL
normal	NULL
PBM	NULL
was	NULL
required	NULL
to	NULL
induce	NULL
the	NULL
generation	NULL
of	NULL
polar	NULL
metabolites	NULL
and	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
.	NULL

The	NULL
lower	NULL
potency	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D3	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
was	NULL
not	NULL
attributable	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
VDR	NULL
content	NULL
,	NULL
as	NULL
the	NULL
maximal	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
;	NULL
-VDR	NULL
specific	NULL
binding	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
PBM	NULL
.	NULL

A	NULL
similar	NULL
functional	NULL
block	NULL
of	NULL
vitamin	NULL
D-dependent	NULL
gene	NULL
regulation	NULL
by	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
has	NULL
been	NULL
described	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
(	NULL
37	NULL
)	NULL
despite	NULL
the	NULL
expression	NULL
of	NULL
VDR	NULL
mRNA	NULL
and	NULL
protein	NULL
suggesting	NULL
that	NULL
factors	NULL
other	NULL
than	NULL
VDR	NULL
content	NULL
determine	NULL
the	NULL
magnitude	NULL
of	NULL
the	NULL
response	NULL
to	NULL
the	NULL
sterol	NULL
.	NULL

A	NULL
role	NULL
for	NULL
the	NULL
state	NULL
of	NULL
differentiation	NULL
rather	NULL
than	NULL
VDR	NULL
levels	NULL
in	NULL
the	NULL
response	NULL
to	NULL
exogenous	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
modulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
osteocalcin	NULL
(	NULL
38	NULL
)	NULL
and	NULL
24-hydroxylase	NULL
genes	NULL
(	NULL
39	NULL
)	NULL
in	NULL
rat	NULL
osteoblasts	NULL
,	NULL
the	NULL
calcium	NULL
binding	NULL
protein	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
crypt	NULL
and	NULL
the	NULL
villus	NULL
of	NULL
the	NULL
intestine	NULL
(	NULL
40	NULL
)	NULL
,	NULL
and	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
in	NULL
HT-29	NULL
human	NULL
colon	NULL
cancer	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
and	NULL
murine	NULL
keratino-cytes	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
our	NULL
studies	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
between	NULL
peripheral	NULL
monocytes	NULL
and	NULL
pulmonary	NULL
alveolar	NULL
macrophages	NULL
supports	NULL
the	NULL
findings	NULL
that	NULL
the	NULL
transcriptional	NULL
and/or	NULL
translational	NULL
steps	NULL
may	NULL
be	NULL
more	NULL
sensitive	NULL
in	NULL
less	NULL
differentiated	NULL
cells	NULL
than	NULL
in	NULL
more	NULL
highly	NULL
differentiated	NULL
(	NULL
mature	NULL
)	NULL
ones	NULL
(	NULL
38-42	NULL
)	NULL
.	NULL

We	NULL
utilized	NULL
phorbol-differentiated	NULL
THP-1	NULL
cells	NULL
to	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
activation	NULL
of	NULL
human	NULL
macrophages	NULL
with	NULL
the	NULL
cytokine	NULL
y-IFN	NULL
,	NULL
responsible	NULL
for	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
overproduction	NULL
by	NULL
PAM	NULL
in	NULL
sarcoidosis	NULL
and	NULL
tuberculosis	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
on	NULL
the	NULL
genomic	NULL
response	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
.	NULL

y-IFN	NULL
markedly	NULL
reduced	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
-mediated	NULL
induction	NULL
of	NULL
its	NULL
own	NULL
degradation	NULL
.	NULL

The	NULL
antagonistic	NULL
effects	NULL
of	NULL
y-IFN	NULL
were	NULL
not	NULL
limited	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
regulation	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
24-hydroxylase	NULL
but	NULL
extended	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
,	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
.	NULL

In	NULL
THP-1	NULL
cells	NULL
,	NULL
yIFN	NULL
decreases	NULL
the	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
a	NULL
concentration	NULL
dependent	NULL
manner	NULL
with	NULL
a	NULL
50	NULL
%	NULL
reduction	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
the	NULL
cytokine	NULL
as	NULL
low	NULL
as	NULL
5	NULL
U/mL	NULL
and	NULL
maximal	NULL
suppression	NULL
for	NULL
concentrations	NULL
above	NULL
20	NULL
IU/mL	NULL
.	NULL

Although	NULL
doses	NULL
higher	NULL
than	NULL
100	NULL
IU/mL	NULL
caused	NULL
a	NULL
mild	NULL
reduction	NULL
in	NULL
maximal	NULL
specific	NULL
binding	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
to	NULL
the	NULL
VDR	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
this	NULL
is	NULL
not	NULL
the	NULL
mechanism	NULL
responsible	NULL
for	NULL
the	NULL
resistance	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
.	NULL

A	NULL
concentration	NULL
of	NULL
y-IFN	NULL
of	NULL
25	NULL
IU/mL	NULL
exerts	NULL
maximal	NULL
inhibition	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
action	NULL
without	NULL
affecting	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
binding	NULL
to	NULL
the	NULL
VDR	NULL
.	NULL

The	NULL
re	NULL
Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
y-INTERFERON	NULL
INHIBITION	NULL
OF	NULL
VITAMIN	NULL
D	NULL
ACTION	NULL
duction	NULL
in	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
a	NULL
post-tanscriptional	NULL
effect	NULL
of	NULL
the	NULL
cytokine	NULL
on	NULL
the	NULL
half-life	NULL
of	NULL
mRNAs	NULL
.	NULL

An	NULL
alternative	NULL
explanation	NULL
for	NULL
the	NULL
reduced	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
is	NULL
that	NULL
y-IFN	NULL
alters	NULL
the	NULL
processing	NULL
of	NULL
the	NULL
24-hydroxylase	NULL
pre-mRNA	NULL
to	NULL
mature	NULL
mRNA	NULL
;	NULL
however	NULL
,	NULL
this	NULL
is	NULL
a	NULL
not	NULL
a	NULL
common	NULL
mechanism	NULL
for	NULL
the	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
steroid	NULL
hormones	NULL
.	NULL

Thus	NULL
,	NULL
y-IFN	NULL
may	NULL
directly	NULL
impair	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
transactivating	NULL
function	NULL
.	NULL

This	NULL
antagonism	NULL
between	NULL
y-IFN	NULL
and	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
is	NULL
physiologically	NULL
relevant	NULL
as	NULL
y-IFN	NULL
also	NULL
impairs	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
.	NULL

24-hydroxylase	NULL
is	NULL
expressed	NULL
in	NULL
almost	NULL
every	NULL
vitamin	NULL
D-responsive	NULL
tissue	NULL
,	NULL
which	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
induction	NULL
of	NULL
24-hydroxylase	NULL
may	NULL
not	NULL
be	NULL
restricted	NULL
to	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

y-IFN	NULL
antagonism	NULL
might	NULL
extend	NULL
to	NULL
renal	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
and	NULL
intestinal	NULL
(	NULL
17	NULL
)	NULL
24-hydroxylases	NULL
,	NULL
the	NULL
major	NULL
contributors	NULL
to	NULL
systemic	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
inactivation	NULL
.	NULL

This	NULL
notion	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
demonstration	NULL
that	NULL
,	NULL
in	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
,	NULL
despite	NULL
the	NULL
supranormal	NULL
serum	NULL
concentrations	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
there	NULL
is	NULL
no	NULL
increase	NULL
in	NULL
the	NULL
metabolic	NULL
clearance	NULL
rate	NULL
of	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
;	NULL
D	NULL
,	NULL
;	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
classical	NULL
vitamin	NULL
D	NULL
responsive	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
(	NULL
44	NULL
)	NULL
suggests	NULL
that	NULL
the	NULL
antagonistic	NULL
effects	NULL
of	NULL
y-IFN	NULL
may	NULL
extend	NULL
to	NULL
other	NULL
vitamin	NULL
D-regulated	NULL
genes	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
y-IFN	NULL
and	NULL
TNFa	NULL
inhibit	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-induced	NULL
osteocalcin	NULL
gene	NULL
transcription	NULL
in	NULL
rat	NULL
osteoablasts	NULL
(	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Both	NULL
cytokines	NULL
also	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
AP-1	NULL
,	NULL
and	NULL
it	NULL
was	NULL
proposed	NULL
that	NULL
cytokine	NULL
inhibition	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-induced	NULL
expression	NULL
of	NULL
osteocalcin	NULL
was	NULL
the	NULL
result	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
AP-1	NULL
DNA-binding	NULL
site	NULL
overlapping	NULL
the	NULL
VDR	NULL
binding	NULL
domain	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
rat	NULL
osteocalcin	NULL
gene	NULL
(	NULL
38	NULL
,	NULL
47	NULL
)	NULL
.	NULL

This	NULL
,	NULL
however	NULL
,	NULL
can	NULL
not	NULL
be	NULL
the	NULL
mechanism	NULL
mediating	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-induction	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
.	NULL

Although	NULL
there	NULL
is	NULL
an	NULL
AP-1	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
human	NULL
24-hydroxylase	NULL
promoter	NULL
(	NULL
44	NULL
)	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
activity	NULL
with	NULL
phorbol	NULL
esters	NULL
stimulates	NULL
rather	NULL
than	NULL
inhibits	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
transactivating	NULL
function	NULL
in	NULL
kidney	NULL
(	NULL
18	NULL
)	NULL
and	NULL
intestinal	NULL
(	NULL
19	NULL
,	NULL
48	NULL
)	NULL
epithelial	NULL
cells	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
necessary	NULL
to	NULL
assess	NULL
whether	NULL
y-IFN	NULL
impairs	NULL
the	NULL
cytoplasmic	NULL
to	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-VDR	NULL
complex	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
complex	NULL
with	NULL
the	NULL
DNA	NULL
,	NULL
or	NULL
steps	NULL
downstream	NULL
in	NULL
the	NULL
assembly	NULL
or	NULL
the	NULL
preini-tiation	NULL
complex	NULL
controlling	NULL
the	NULL
rate	NULL
of	NULL
24-hydroxylase	NULL
gene	NULL
transcription	NULL
.	NULL

Recent	NULL
studies	NULL
of	NULL
the	NULL
mechanisms	NULL
for	NULL
the	NULL
inhibition	NULL
by	NULL
TNFa	NULL
of	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
,	NULL
modulation	NULL
of	NULL
osteocalcin	NULL
gene	NULL
expression	NULL
demonstrated	NULL
that	NULL
the	NULL
cytokine	NULL
induces	NULL
an	NULL
intranu-clear	NULL
repressor	NULL
that	NULL
decreases	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-stimulated	NULL
retinoid	NULL
X	NULL
receptor-VDR	NULL
binding	NULL
to	NULL
the	NULL
vitamin	NULL
D	NULL
responsive	NULL
element	NULL
of	NULL
the	NULL
rat	NULL
osteocalcin	NULL
gene	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
involved	NULL
is	NULL
different	NULL
from	NULL
the	NULL
AP-1	NULL
binding	NULL
domain	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

There	NULL
has	NULL
been	NULL
no	NULL
further	NULL
characterization	NULL
of	NULL
the	NULL
mechanisms	NULL
mediating	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
y-IFN	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
-induction	NULL
of	NULL
the	NULL
rat	NULL
osteocalcin	NULL
gene	NULL
,	NULL
except	NULL
for	NULL
the	NULL
demonstration	NULL
that	NULL
,	NULL
unlike	NULL
TNFa	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
y-IFN	NULL
require	NULL
ongoing	NULL
protein	NULL
synthesis	NULL
(	NULL
45	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
studies	NULL
presented	NULL
here	NULL
illustrate	NULL
that	NULL
,	NULL
in	NULL
2231	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
macrophage	NULL
lineage	NULL
,	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
,	NULL
suppression	NULL
of	NULL
its	NULL
synthesis	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
rapid	NULL
,	NULL
nongenomic	NULL
mechanisms	NULL
and	NULL
that	NULL
the	NULL
sterol	NULL
induces	NULL
its	NULL
catabolism	NULL
by	NULL
enhancing	NULL
24-hydroxylase	NULL
mRNA	NULL
levels	NULL
and	NULL
activity	NULL
.	NULL

The	NULL
resistance	NULL
of	NULL
activated	NULL
PAM	NULL
to	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
in	NULL
the	NULL
control	NULL
of	NULL
its	NULL
own	NULL
production	NULL
can	NULL
not	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
the	NULL
reduced	NULL
sensitivity	NULL
to	NULL
the	NULL
sterol	NULL
as	NULL
monocytes	NULL
differentiate	NULL
to	NULL
macrophages	NULL
,	NULL
but	NULL
results	NULL
from	NULL
potent	NULL
antagonistic	NULL
effects	NULL
of	NULL
the	NULL
cytokine	NULL
y-IFEN	NULL
on	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
action	NULL
.	NULL

These	NULL
findings	NULL
could	NULL
explain	NULL
the	NULL
excessive	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
,	NULL
D	NULL
;	NULL
production	NULL
induced	NULL
by	NULL
y-IFN	NULL
in	NULL
PAM	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
and	NULL
tuberculosis	NULL
,	NULL
and	NULL
they	NULL
demonstrate	NULL
the	NULL
existence	NULL
of	NULL
interactions	NULL
at	NULL
the	NULL
level	NULL
of	NULL
gene	NULL
transcription	NULL
between	NULL
the	NULL
cytokine	NULL
y-IFN	NULL
and	NULL
the	NULL
steroid	NULL
hormone	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
immune	NULL
cells	NULL
in	NULL
humans	NULL
.	NULL

Because	NULL
macrophages	NULL
in	NULL
different	NULL
tissues	NULL
display	NULL
variable	NULL
phenotypes	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
,	NULL
assessment	NULL
of	NULL
a	NULL
role	NULL
for	NULL
y-IFN-1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
,	NULL
antagonism	NULL
in	NULL
the	NULL
hypercalcemia	NULL
of	NULL
other	NULL
in-flamatory	NULL
conditions	NULL
awaits	NULL
evaluation	NULL
of	NULL
cytokine-1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
,	NULL
D	NULL
;	NULL
interactions	NULL
in	NULL
macrophages	NULL
from	NULL
tissues	NULL
involved	NULL
in	NULL
those	NULL
disorders	NULL
.	NULL

Since	NULL
both	NULL
y-IFN	NULL
and	NULL
1,25	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
are	NULL
potent	NULL
modulators	NULL
of	NULL
cell	NULL
growth	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
immune	NULL
function	NULL
(	NULL
53-57	NULL
)	NULL
,	NULL
the	NULL
observed	NULL
antagonism	NULL
may	NULL
have	NULL
pathophysiological	NULL
repercussions	NULL
in	NULL
inflammatory	NULL
processes	NULL
beyond	NULL
those	NULL
causing	NULL
abnormal	NULL
calcium	NULL
homeostasis	NULL
.	NULL

Acknowledgments	NULL
The	NULL
authors	NULL
thank	NULL
Dr.	NULL
Alex	NULL
Brown	NULL
and	NULL
Dr.	NULL
Christine	NULL
Sorenson	NULL
for	NULL
valuable	NULL
comments	NULL
and	NULL
review	NULL
of	NULL
this	NULL
manuscript	NULL
,	NULL
Jane	NULL
Finch	NULL
for	NULL
her	NULL
assistance	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
Ron	NULL
McCarthy	NULL
in	NULL
Dr.	NULL
Shapiro	NULL
's	NULL
laboratory	NULL
for	NULL
his	NULL
technical	NULL
assistance	NULL
in	NULL
providing	NULL
the	NULL
alveolar	NULL
macrophages	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Dusso	NULL
A	NULL
,	NULL
Brown	NULL
A	NULL
,	NULL
Slatopolsky	NULL
E.	NULL
1994	NULL
Extrarenal	NULL
production	NULL
of	NULL
calcitriol	NULL
.	NULL

Semin	NULL
Nephrol	NULL
.	NULL

14:144-155	NULL
.	NULL

2	NULL
.	NULL

Walters	NULL
MR.	NULL
1992	NULL
Newly	NULL
identified	NULL
actions	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
endocrine	NULL
system	NULL
.	NULL

Endocr	NULL
Rev	NULL
.	NULL

13:719-764	NULL
.	NULL

3	NULL
.	NULL

Brown	NULL
A	NULL
,	NULL
Dusso	NULL
A	NULL
,	NULL
E.	NULL
Slatopolsky	NULL
.	NULL

1992	NULL
Vitamin	NULL
D.	NULL
In	NULL
:	NULL
Seldin	NULL
DW	NULL
,	NULL
Geibish	NULL
G	NULL
,	NULL
eds	NULL
.	NULL

The	NULL
kidney	NULL
:	NULL
physiology	NULL
and	NULL
pathophysiology	NULL
.	NULL

pp	NULL
1505-1551	NULL
.	NULL

4	NULL
.	NULL

Hughes	NULL
MR	NULL
,	NULL
Baylink	NULL
DJ	NULL
,	NULL
Jones	NULL
PG	NULL
,	NULL
Haussler	NULL
MR.	NULL
1976	NULL
Radioligand	NULL
receptor	NULL
assay	NULL
for	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
/D	NULL
;	NULL
.	NULL

Application	NULL
to	NULL
hypervitaminosis	NULL
D.	NULL
J	NULL
Cin	NULL
Invest	NULL
.	NULL

58:61-70	NULL
.	NULL

5	NULL
.	NULL

Sandler	NULL
LM	NULL
,	NULL
Winearls	NULL
CG	NULL
,	NULL
Fraher	NULL
LJ	NULL
,	NULL
Clemens	NULL
TL	NULL
,	NULL
Smith	NULL
R	NULL
,	NULL
O'Riordan	NULL
JLH	NULL
.	NULL

1984	NULL
Studies	NULL
of	NULL
the	NULL
hypercalcemia	NULL
of	NULL
sarcoidosis	NULL
:	NULL
effect	NULL
of	NULL
steroids	NULL
and	NULL
exogenous	NULL
vitamin	NULL
D	NULL
;	NULL
on	NULL
the	NULL
circulating	NULL
concentrations	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

QJ	NULL
Med	NULL
.	NULL

53:165-180	NULL
.	NULL

6	NULL
.	NULL

Adams	NULL
JS	NULL
,	NULL
Gacad	NULL
MA	NULL
,	NULL
Andres	NULL
A	NULL
,	NULL
Endres	NULL
DF	NULL
,	NULL
Sharma	NULL
OP	NULL
.	NULL

1986	NULL
Biochemical	NULL
indicators	NULL
of	NULL
disordered	NULL
vitamin	NULL
D	NULL
and	NULL
calcium	NULL
homeostasis	NULL
in	NULL
sarcoidosis	NULL
.	NULL

Sarcoidosis	NULL
.	NULL

3:1-6	NULL
.	NULL

7	NULL
.	NULL

Lambert	NULL
PW	NULL
,	NULL
Stern	NULL
PH	NULL
,	NULL
Avioli	NULL
RC	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1982	NULL
Evidence	NULL
for	NULL
extrarenal	NULL
production	NULL
of	NULL
14,25-dihydroxyvitamin	NULL
D	NULL
in	NULL
man	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
.	NULL

69:722-725	NULL
.	NULL

8	NULL
.	NULL

Gkonos	NULL
PJ	NULL
,	NULL
London	NULL
R	NULL
,	NULL
Hendler	NULL
ED	NULL
.	NULL

1984	NULL
Hypercalcemia	NULL
and	NULL
elevated	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
levels	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
end	NULL
stage	NULL
renal	NULL
disease	NULL
and	NULL
active	NULL
tuberculosis	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
.	NULL

311:1683-1685	NULL
.	NULL

9	NULL
.	NULL

Gates	NULL
S	NULL
,	NULL
Shary	NULL
J	NULL
,	NULL
Turner	NULL
RT	NULL
,	NULL
Wallach	NULL
S	NULL
,	NULL
Bell	NULL
NH	NULL
.	NULL

1986	NULL
Abnormal	NULL
calcium	NULL
metabolism	NULL
caused	NULL
by	NULL
increased	NULL
circulating	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J	NULL
Bone	NULL
Miner	NULL
Res	NULL
.	NULL

1:221-226	NULL
.	NULL

10	NULL
.	NULL

Reichel	NULL
H	NULL
,	NULL
Koeffler	NULL
HP	NULL
,	NULL
Norman	NULL
AW	NULL
.	NULL

1987	NULL
Regulation	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
production	NULL
by	NULL
cultured	NULL
alveolar	NULL
macrophages	NULL
from	NULL
normal	NULL
human	NULL
donors	NULL
and	NULL
from	NULL
patients	NULL
with	NULL
pulmonary	NULL
sarcoidosis	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
.	NULL

65:1201-1209	NULL
.	NULL

11	NULL
.	NULL

Adams	NULL
JS	NULL
,	NULL
Gacad	NULL
MA	NULL
.	NULL

1985	NULL
Characterization	NULL
of	NULL
la-hydroxylation	NULL
of	NULL
vitamin	NULL
D	NULL
;	NULL
sterols	NULL
by	NULL
cultured	NULL
alveolar	NULL
macrophages	NULL
from	NULL
patients	NULL
with	NULL
sarcoidosis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
.	NULL

161:755-765	NULL
.	NULL

12	NULL
.	NULL

Dusso	NULL
AS	NULL
,	NULL
Finch	NULL
J	NULL
,	NULL
Brown	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1991	NULL
Extrarenal	NULL
production	NULL
of	NULL
calcitriol	NULL
in	NULL
normal	NULL
and	NULL
uremic	NULL
humans	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
.	NULL

72:157-164	NULL
.	NULL

13	NULL
.	NULL

Gallieni	NULL
M	NULL
,	NULL
Kamimura	NULL
S	NULL
,	NULL
Ahmed	NULL
A	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
Kinetics	NULL
of	NULL
monocyte	NULL
1-hydroxylase	NULL
in	NULL
chronic	NULL
renal	NULL
failure	NULL
.	NULL

Am	NULL
]	NULL
Physiol	NULL
.	NULL

268	NULL
:	NULL
F746-F753	NULL
.	NULL

14	NULL
.	NULL

Halloran	NULL
BP	NULL
,	NULL
Castro	NULL
ME	NULL
.	NULL

1989	NULL
Vitmin	NULL
D	NULL
kinetics	NULL
fn	NULL
vivo	NULL
:	NULL
effect	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
administration	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
.	NULL

256	NULL
:	NULL
E686-E691	NULL
.	NULL

Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL
22832	NULL
15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

Reddy	NULL
GS	NULL
,	NULL
Tserng	NULL
K.	NULL
1989	NULL
Calcitriol	NULL
acid	NULL
,	NULL
end	NULL
product	NULL
of	NULL
renal	NULL
metabolism	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
through	NULL
C-24	NULL
oxidation	NULL
pathway	NULL
.	NULL

Biochemistry	NULL
.	NULL

28:11763-1769	NULL
.	NULL

Makin	NULL
G	NULL
,	NULL
Lohnes	NULL
D	NULL
,	NULL
Byford	NULL
V	NULL
,	NULL
Ray	NULL
R	NULL
,	NULL
Jones	NULL
G.	NULL
1989	NULL
Target	NULL
cell	NULL
metabolism	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
Ds	NULL
;	NULL
to	NULL
calcitriol	NULL
acid	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
pathway	NULL
in	NULL
kidney	NULL
and	NULL
bone	NULL
involving	NULL
24-oxidation	NULL
.	NULL

Biochem	NULL
J	NULL
.	NULL

262:173-180	NULL
.	NULL

Tomon	NULL
M	NULL
,	NULL
Tennenhouse	NULL
HS	NULL
,	NULL
Jones	NULL
G.	NULL
1990	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
in-ducible	NULL
catabolism	NULL
of	NULL
vitamin	NULL
D	NULL
metabolites	NULL
in	NULL
mouse	NULL
intestine	NULL
.	NULL

Am	NULL
J	NULL
Physiol	NULL
.	NULL

258:1763-1769	NULL
.	NULL

Chen	NULL
ML	NULL
,	NULL
Boltz	NULL
MA	NULL
,	NULL
Armbrecht	NULL
HJ	NULL
.	NULL

1993	NULL
Effects	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
and	NULL
phorbol	NULL
ester	NULL
on	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
24-hydroxylase	NULL
cytochrome	NULL
P450	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
levels	NULL
in	NULL
primary	NULL
cultures	NULL
of	NULL
rat	NULL
renal	NULL
cells	NULL
.	NULL

Endocrinology	NULL
.	NULL

132:1782-1788	NULL
.	NULL

Atrmbrecht	NULL
HJ	NULL
,	NULL
Hodam	NULL
TL	NULL
,	NULL
Boltz	NULL
MA	NULL
,	NULL
Chen	NULL
ML	NULL
.	NULL

1993	NULL
Phorbol	NULL
ester	NULL
markedly	NULL
increases	NULL
the	NULL
sensitivity	NULL
of	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
to	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
,	NULL
.	NULL

FEBS	NULL
.	NULL

327:13-16	NULL
.	NULL

Kerr	NULL
Whitefield	NULL
G	NULL
,	NULL
Hsieh	NULL
JG	NULL
,	NULL
Jurutka	NULL
PW	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
Genomic	NULL
actions	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

J	NULL
Nutr	NULL
.	NULL

125:16905-16945	NULL
.	NULL

Pryke	NULL
AM	NULL
,	NULL
Duggan	NULL
C	NULL
,	NULL
White	NULL
CP	NULL
,	NULL
Posen	NULL
S	NULL
,	NULL
Mason	NULL
RS	NULL
.	NULL

1990	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
vitamin	NULL
D-1-hydroxylase	NULL
activity	NULL
in	NULL
normal	NULL
human	NULL
alveolar	NULL
macrophages	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
.	NULL

142:652-656.	NULL
.	NULL

Pryke	NULL
AM	NULL
,	NULL
White	NULL
CP	NULL
,	NULL
Ranson	NULL
M	NULL
,	NULL
Mason	NULL
RS	NULL
.	NULL

1987	NULL
Macrophage	NULL
activation	NULL
by	NULL
gamma	NULL
interferon	NULL
does	NULL
not	NULL
inhibit	NULL
binding	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

J	NULL
Bone	NULL
Miner	NULL
Res	NULL
.	NULL

1:65	NULL
(	NULL
Abstract	NULL
)	NULL
.	NULL

Kamimura	NULL
S	NULL
,	NULL
Gallieni	NULL
M	NULL
,	NULL
Zhong	NULL
M	NULL
,	NULL
Beron	NULL
W	NULL
,	NULL
Slatopolsky	NULL
E	NULL
,	NULL
Dusso	NULL
A	NULL
.	NULL

1995	NULL
Microtubules	NULL
mediate	NULL
cellular	NULL
250HD	NULL
;	NULL
trafficking	NULL
and	NULL
the	NULL
genomic	NULL
response	NULL
to	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
normal	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

270:22160-22166	NULL
.	NULL

Kamimura	NULL
S	NULL
,	NULL
Gallieni	NULL
M	NULL
,	NULL
Kubodera	NULL
N	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
Differential	NULL
catabolism	NULL
of	NULL
22-oxacalcitriol	NULL
and	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
by	NULL
normal	NULL
human	NULL
peripheral	NULL
monocytes	NULL
.	NULL

Endocrinology	NULL
.	NULL

133:2719-2723.	NULL
.	NULL

Yam	NULL
LT	NULL
,	NULL
Li	NULL
CY	NULL
.	NULL

1971	NULL
Cytochemical	NULL
identification	NULL
of	NULL
monocytes	NULL
and	NULL
granulo-	NULL
cytes	NULL
.	NULL

J	NULL
Pathol	NULL
.	NULL

55:91-98	NULL
.	NULL

Senior	NULL
RM	NULL
,	NULL
Connolly	NULL
NL	NULL
,	NULL
Cury	NULL
JD	NULL
,	NULL
Welgus	NULL
HG	NULL
,	NULL
Campbell	NULL
EJ	NULL
.	NULL

1989	NULL
Elastin	NULL
degradation	NULL
by	NULL
human	NULL
alveolar	NULL
macrophages	NULL
.	NULL

A	NULL
prominent	NULL
role	NULL
of	NULL
metalloproteinase	NULL
activity	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
.	NULL

139:1251-1256	NULL
.	NULL

Shapiro	NULL
SD	NULL
,	NULL
Campbell	NULL
EJ	NULL
,	NULL
Kobayashi	NULL
DK	NULL
,	NULL
Welgus	NULL
HG	NULL
.	NULL

1990	NULL
Immune	NULL
modulation	NULL
of	NULL
metalloproteinase	NULL
production	NULL
in	NULL
human	NULL
macrophages	NULL
.	NULL

Selective	NULL
translational	NULL
suppression	NULL
of	NULL
interstitial	NULL
collagenase	NULL
and	NULL
stromelysin	NULL
biosyn-thesis	NULL
by	NULL
interferon-gamma	NULL
.	NULL
]	NULL

Clin	NULL
Invest	NULL
.	NULL

96:1204:1210	NULL
.	NULL

Tsuchiya	NULL
S	NULL
,	NULL
Kobayashi	NULL
Y	NULL
,	NULL
Goto	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1982	NULL
Induction	NULL
of	NULL
maturation	NULL
in	NULL
cultured	NULL
human	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
phorbol	NULL
diester	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

42:1530-1536	NULL
.	NULL

Burgos-Trinidad	NULL
M	NULL
,	NULL
Brown	NULL
AJ	NULL
,	NULL
DeLuca	NULL
HF	NULL
.	NULL

1990	NULL
A	NULL
rapid	NULL
assay	NULL
for	NULL
25-hydroxyvitamin	NULL
D	NULL
and	NULL
1,25-dihydroxyvitamin	NULL
D24-hydroxylase	NULL
.	NULL

Anal	NULL
Biochem	NULL
.	NULL

190:102-107	NULL
.	NULL

Beckman	NULL
MJ	NULL
,	NULL
Tadikonda	NULL
P	NULL
,	NULL
Werner	NULL
E	NULL
,	NULL
Prah	NULL
]	NULL
l	NULL
J	NULL
,	NULL
Yamada	NULL
S	NULL
,	NULL
DeLuca	NULL
HF	NULL
.	NULL

1996	NULL
Human	NULL
25-hyroxyvitamin	NULL
D	NULL
;	NULL
-24-hydroxylase	NULL
,	NULL
a	NULL
multicatalytic	NULL
enzyme	NULL
.	NULL

Biochemistry	NULL
.	NULL

35:8465-8472	NULL
.	NULL

Reinhardt	NULL
TA	NULL
,	NULL
Horst	NULL
RL	NULL
,	NULL
Orf	NULL
W	NULL
,	NULL
Hollis	NULL
BW	NULL
.	NULL

1984	NULL
A	NULL
microassay	NULL
for	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
not	NULL
requiring	NULL
high	NULL
performance	NULL
liquid	NULL
chromatography	NULL
:	NULL
applications	NULL
to	NULL
clinical	NULL
studies	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
.	NULL

58:91-98	NULL
.	NULL

Meyrier	NULL
A	NULL
,	NULL
Valeyre	NULL
D	NULL
,	NULL
Bouillon	NULL
R	NULL
,	NULL
Paillard	NULL
F	NULL
,	NULL
Battesti	NULL
JP	NULL
,	NULL
Georges	NULL
R.	NULL
1985	NULL
Resorptive	NULL
versus	NULL
absorptive	NULL
hypercalciuria	NULL
in	NULL
sarcoidosis	NULL
:	NULL
correlations	NULL
with	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
and	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
and	NULL
parameteres	NULL
of	NULL
disease	NULL
activity	NULL
.	NULL

Q	NULL
J	NULL
Med	NULL
.	NULL

54:269-281	NULL
.	NULL

Adams	NULL
JS	NULL
,	NULL
Modlin	NULL
RL	NULL
,	NULL
Diz	NULL
MM	NULL
,	NULL
Barnes	NULL
PF	NULL
.	NULL

1989	NULL
Potentiation	NULL
of	NULL
the	NULL
macrophage	NULL
25-hydroxyvitamin	NULL
D-1-hydroxylation	NULL
reaction	NULL
by	NULL
human	NULL
tuberculous	NULL
pleural	NULL
effusion	NULL
fluid	NULL
.	NULL

1989	NULL
J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
.	NULL

69:457-460	NULL
.	NULL

Dick	NULL
IM	NULL
,	NULL
Retallack	NULL
R	NULL
,	NULL
Prince	NULL
RL	NULL
.	NULL

1990	NULL
Rapid	NULL
nongenomic	NULL
inhibition	NULL
of	NULL
renal	NULL
25-hydroxyvitamin	NULL
D	NULL
;	NULL
1-hydroxylase	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
.	NULL

Am	NULL
]	NULL
Physiol	NULL
.	NULL

259:272-277	NULL
.	NULL

Yoshizawa	NULL
T	NULL
,	NULL
Hasanda	NULL
Y	NULL
,	NULL
Uematsu	NULL
Y	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
Disruption	NULL
of	NULL
the	NULL
vitamin	NULL
D	NULL
receptor	NULL
(	NULL
VDR	NULL
)	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

J	NULL
Bone	NULL
Miner	NULL
Res	NULL
.	NULL

11:5124	NULL
(	NULL
Abstract	NULL
)	NULL
.	NULL

Auwerx	NULL
J	NULL
.	NULL

1991	NULL
The	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
THP-1	NULL
:	NULL
A	NULL
multifacetted	NULL
model	NULL
for	NULL
the	NULL
study	NULL
of	NULL
monocyte-macrophage	NULL
differentiation	NULL
.	NULL

Experientia	NULL
.	NULL

47:22-31	NULL
.	NULL

DUSSO	NULL
ET	NULL
AL	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

JCE	NULL
&	NULL
M	NULL
»	NULL
1997	NULL
Vol	NULL
82	NULL
«	NULL
No	NULL
7	NULL
Morgan	NULL
JW	NULL
,	NULL
Reddy	NULL
GS	NULL
,	NULL
Uskokovic	NULL
MR	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
Functional	NULL
block	NULL
for	NULL
1	NULL
@	NULL
,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
mediated	NULL
gene	NULL
regulation	NULL
in	NULL
human	NULL
B	NULL
lympho-cytes	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
.	NULL

269:13437-13443	NULL
.	NULL

Owen	NULL
TA	NULL
,	NULL
Bortell	NULL
R	NULL
,	NULL
Yocum	NULL
SA	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
Coordinate	NULL
occupancy	NULL
of	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
vitamin	NULL
D-responsive	NULL
and	NULL
CCAAT	NULL
box	NULL
elements	NULL
by	NULL
Fos-Jun	NULL
in	NULL
the	NULL
osteocalcin	NULL
gene	NULL
:	NULL
model	NULL
for	NULL
phenotype	NULL
suppression	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
.	NULL

87:9990-9994	NULL
.	NULL

Nishimura	NULL
A	NULL
,	NULL
Shinki	NULL
T	NULL
,	NULL
Jin	NULL
CH	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
Regulation	NULL
of	NULL
messenger	NULL
ribonucleic	NULL
acid	NULL
expression	NULL
of	NULL
1	NULL
@	NULL
,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
-24-hydroxylase	NULL
in	NULL
rat	NULL
os-teoblasts	NULL
.	NULL

Endocrinology	NULL
.	NULL

134:1794-1799	NULL
.	NULL

Shinki	NULL
T	NULL
,	NULL
Takahashi	NULL
N	NULL
,	NULL
Kawate	NULL
N	NULL
,	NULL
Suda	NULL
T.	NULL
1982	NULL
The	NULL
possible	NULL
role	NULL
of	NULL
calcium	NULL
binding	NULL
protein	NULL
induced	NULL
by	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
in	NULL
the	NULL
intestinal	NULL
calcium	NULL
transport	NULL
mechanism	NULL
.	NULL

Endocrinology	NULL
.	NULL

111:1546-1551	NULL
.	NULL

Zhao	NULL
X	NULL
,	NULL
Feldman	NULL
D.	NULL
1993	NULL
Regulation	NULL
of	NULL
vitamin	NULL
D	NULL
receptor	NULL
abundance	NULL
and	NULL
responsiveness	NULL
during	NULL
differentiation	NULL
of	NULL
HT-29	NULL
human	NULL
colon	NULL
cancer	NULL
cells	NULL
.	NULL

Endocrinology	NULL
.	NULL

132:1808-1814.	NULL
.	NULL

Rizk-Rabin	NULL
M	NULL
,	NULL
Zineb	NULL
R	NULL
,	NULL
Zhor	NULL
B	NULL
,	NULL
Garabedian	NULL
M	NULL
,	NULL
Jana	NULL
P.	NULL
1994	NULL
Synthesis	NULL
of	NULL
and	NULL
response	NULL
to	NULL
1,25-dihydroxycholecalciferol	NULL
by	NULL
subpopulations	NULL
of	NULL
murine	NULL
epidermal	NULL
keratinocytes	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
paracrine	NULL
system	NULL
for	NULL
.	NULL

1:25-dihydroxy-cholecalciferol	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
.	NULL

159:131-141.	NULL
.	NULL

Insogna	NULL
KL	NULL
,	NULL
Dreyer	NULL
BE	NULL
,	NULL
Mitnick	NULL
M	NULL
,	NULL
Ellison	NULL
AF	NULL
,	NULL
Broadus	NULL
AE	NULL
.	NULL

1988	NULL
Enhanced	NULL
production	NULL
rate	NULL
of	NULL
1,25-dihydroxyviamin	NULL
D	NULL
in	NULL
sarcoidosis	NULL
.	NULL

J	NULL
Clin	NULL
Endocrinol	NULL
Metab	NULL
.	NULL

66:72-75.	NULL
.	NULL

Chen	NULL
KS	NULL
,	NULL
DeLuca	NULL
HF	NULL
.	NULL

1995	NULL
Cloning	NULL
of	NULL
the	NULL
human	NULL
D-3	NULL
24-hydroxylase	NULL
gene	NULL
promoter	NULL
and	NULL
identification	NULL
of	NULL
two	NULL
vitamin	NULL
D-responsive	NULL
elements	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
.	NULL

1263:1-9.	NULL
.	NULL

Nanes	NULL
MS	NULL
,	NULL
Rubin	NULL
J	NULL
,	NULL
Titus	NULL
L	NULL
,	NULL
Hendy	NULL
GN	NULL
,	NULL
Catherwood	NULL
BD	NULL
.	NULL

1990	NULL
Interferon	NULL
gamma	NULL
inhibits	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
stimulated	NULL
synthesis	NULL
of	NULL
bone	NULL
gla	NULL
protein	NULL
in	NULL
rat	NULL
osteosarcoma	NULL
cells	NULL
by	NULL
a	NULL
pretranslational	NULL
mechanism	NULL
.	NULL

Endoctri-nology	NULL
.	NULL

127:588-594	NULL
.	NULL

Nanes	NULL
MS	NULL
,	NULL
Rubin	NULL
J	NULL
,	NULL
Titus	NULL
L	NULL
,	NULL
Hendy	NULL
GN	NULL
,	NULL
Catherwood	NULL
BD	NULL
.	NULL

1991	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
inhibits	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
-stimulated	NULL
bone	NULL
gla	NULL
protein	NULL
synthesis	NULL
in	NULL
rat	NULL
osteosarcoma	NULL
cells	NULL
(	NULL
ROS	NULL
17/2.8	NULL
)	NULL
by	NULL
a	NULL
pretranslational	NULL
mechanism	NULL
.	NULL

Endocrinology	NULL
.	NULL

128:2577-2582	NULL
.	NULL

Lian	NULL
JB	NULL
,	NULL
Stein	NULL
GS	NULL
,	NULL
Bortell	NULL
R	NULL
,	NULL
Owen	NULL
TA	NULL
.	NULL

1991	NULL
Phenotype	NULL
suppression	NULL
:	NULL
a	NULL
postulated	NULL
molecular	NULL
mechanism	NULL
for	NULL
mediating	NULL
the	NULL
relationship	NULL
of	NULL
proliferation	NULL
and	NULL
differentiation	NULL
by	NULL
Fos/Jun	NULL
interactions	NULL
at	NULL
AP-1	NULL
sites	NULL
in	NULL
steroid	NULL
responsive	NULL
promoter	NULL
elements	NULL
of	NULL
tissue	NULL
specific-	NULL
genes	NULL
.	NULL

J	NULL
Cell	NULL
Biochem	NULL
.	NULL

45:9-14	NULL
.	NULL

Koyama	NULL
H	NULL
,	NULL
Inaba	NULL
M	NULL
,	NULL
Nishizawa	NULL
Y	NULL
,	NULL
Ohno	NULL
S	NULL
,	NULL
Morii	NULL
H.	NULL
1994	NULL
Protein	NULL
kinase	NULL
C	NULL
is	NULL
involved	NULL
in	NULL
24-hydroxylase	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
1,25-	NULL
(	NULL
OH	NULL
)	NULL
;	NULL
D	NULL
;	NULL
in	NULL
rat	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biochem	NULL
.	NULL

55:230-240	NULL
.	NULL

Kuno	NULL
H	NULL
,	NULL
Kurian	NULL
SM	NULL
,	NULL
Hendy	NULL
GN	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
Inhibition	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
stimulated	NULL
osteocalcin	NULL
gene	NULL
transcription	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
:	NULL
Structural	NULL
determinants	NULL
within	NULL
the	NULL
vitamin	NULL
D	NULL
response	NULL
element	NULL
.	NULL

Endocrinology	NULL
.	NULL

134:2524-2531	NULL
.	NULL

Fernandez-Martin	NULL
JL	NULL
,	NULL
Kurian	NULL
S	NULL
,	NULL
Nanes	NULL
MS.	NULL
1996	NULL
TNFa	NULL
induces	NULL
an	NULL
intranu-clear	NULL
repressor	NULL
that	NULL
inhibits	NULL
vitamin	NULL
D	NULL
and	NULL
retinoid	NULL
X	NULL
receptor	NULL
function	NULL
.	NULL

J	NULL
Bone	NULL
Miner	NULL
Res	NULL
.	NULL

11:5114	NULL
(	NULL
Abstract	NULL
)	NULL
.	NULL

Gordon	NULL
S	NULL
,	NULL
Perry	NULL
VH	NULL
,	NULL
Rabinowitz	NULL
S	NULL
,	NULL
Chung	NULL
LP	NULL
,	NULL
Rosen	NULL
H.	NULL
1988	NULL
Plasma	NULL
membrane	NULL
receptors	NULL
of	NULL
the	NULL
mononuclear	NULL
phagocyte	NULL
system	NULL
.	NULL

J	NULL
Cell	NULL
Sci	NULL
.	NULL

9:1-26	NULL
.	NULL

Rappolee	NULL
DA	NULL
,	NULL
Werb	NULL
Z	NULL
.	NULL

1992	NULL
Macrophage	NULL
derived	NULL
growth	NULL
factors	NULL
.	NULL

Curr	NULL
Top	NULL
Microb	NULL
Immunol	NULL
.	NULL

181:87-140	NULL
.	NULL

Trinchieri	NULL
G	NULL
,	NULL
Perussia	NULL
B	NULL
.	NULL

1985	NULL
Immune	NULL
interferon	NULL
:	NULL
a	NULL
pleiotropic	NULL
lymphokine	NULL
with	NULL
multiple	NULL
effects	NULL
.	NULL

Immunol	NULL
Today	NULL
.	NULL

6:131-136	NULL
.	NULL

Romeo	NULL
G	NULL
,	NULL
Fiorucci	NULL
G	NULL
,	NULL
Rossi	NULL
GB	NULL
.	NULL

1989	NULL
Interferons	NULL
in	NULL
cell	NULL
growth	NULL
and	NULL
devel-opment	NULL
.	NULL

Trend	NULL
Genet	NULL
.	NULL

5:19-24	NULL
.	NULL

Lemire	NULL
JM	NULL
.	NULL

1992	NULL
;	NULL
Immunomodulatory	NULL
role	NULL
of	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
,	NULL
J	NULL
Cell	NULL
Biochem	NULL
.	NULL

49:26-31	NULL
.	NULL

Bar-Shavit	NULL
Z	NULL
,	NULL
Noff	NULL
D	NULL
,	NULL
Eldestein	NULL
S	NULL
,	NULL
Meyer	NULL
M	NULL
,	NULL
Shibolet	NULL
S	NULL
,	NULL
Goldman	NULL
R.	NULL
1981	NULL
1,25-dihydroxyvitamin	NULL
D	NULL
;	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
macrophage	NULL
function	NULL
.	NULL

Calcif	NULL
Tissue	NULL
Int	NULL
.	NULL

33:673-676	NULL
.	NULL

Yang	NULL
S	NULL
,	NULL
Smith	NULL
C	NULL
,	NULL
Prahl	NULL
JM	NULL
,	NULL
Luo	NULL
X	NULL
,	NULL
DeLuca	NULL
HF	NULL
.	NULL

1993	NULL
Vitamin	NULL
D	NULL
rickets	NULL
suppresses	NULL
cell	NULL
mediated	NULL
immunity	NULL
in	NULL
vivo	NULL
.	NULL

Arch	NULL
Biochem	NULL
Biophys	NULL
.	NULL

303:98-106	NULL
.	NULL

Downloaded	NULL
from	NULL
jcem.endojournals.org	NULL
on	NULL
August	NULL
11	NULL
,	NULL
2005	NULL

